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Suranga N. Kasthurirathne 
THE USE OF CLINICAL, BEHAVIORAL, AND SOCIAL DETERMINANTS OF 
HEALTH TO IMPROVE IDENTIFICATION OF PATIENTS IN NEED OF 
ADVANCED CARE FOR DEPRESSION 
 Depression is the most commonly occurring mental illness the world over. It poses 
a significant health and economic burden across the individual and community. Not all 
occurrences of depression require the same level of treatment. However, identifying 
patients in need of advanced care has been challenging and presents a significant bottleneck 
in providing care. We developed a knowledge-driven depression taxonomy comprised of 
features representing clinical, behavioral, and social determinants of health (SDH) that 
inform the onset, progression, and outcome of depression. We leveraged the depression 
taxonomy to build decision models that predicted need for referrals across: (a) the overall 
patient population and (b) various high-risk populations. Decision models were built using 
longitudinal, clinical, and behavioral data extracted from a population of 84,317 patients 
seeking care at Eskenazi Health of Indianapolis, Indiana. Each decision model yielded 
significantly high predictive performance. However, models predicting need of treatment 
across high-risk populations (ROC’s of 86.31% to 94.42%) outperformed models 
representing the overall patient population (ROC of 78.87%). Next, we assessed the value 
of adding SDH into each model. For each patient population under study, we built 
additional decision models that incorporated a wide range of patient and aggregate-level 
SDH and compared their performance against the original models. Models that 
incorporated SDH yielded high predictive performance. However, use of SDH did not yield 
statistically significant performance improvements. Our efforts present significant 
potential to identify patients in need of advanced care using a limited number of clinical 
and behavioral features. However, we found no benefit to incorporating additional SDH 
into these models. Our methods can also be applied across other datasets in response to a 
wide variety of healthcare challenges. 
 
 
Josette Jones, RN, PhD, Chair 
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LIST OF DEFINITIONS 
 Social Determinants of Health (SDH): Conditions in the environment in which 
people are born, live, learn, work, play, worship, and age that affect a wide range of health, 
functioning, and quality-of-life outcomes and risks (Marmot et al., 2008; Office of Disease 
Prevention and Health Promotion, 2014). 
 Patients in need of advanced care for depression: Patients suffering from depression 
whose quality of life and/or health status will degrade if they do not receive specialized 
treatment above and beyond primary care. 
1 INTRODUCTION 
 Mental health issues are widespread and have the potential to influence other health 
conditions, leading to a significant strain on national resources and impacting overall 
quality of life. An estimated 43.6 million (18.1%), or roughly one in five Americans age 
18 and over have experienced some form of mental illness during the year 2014 (Substance 
Abuse and Mental Health Services Administration, 2014). The latest available data 
indicates that approximately 11 million adults, or 4.8% of the U.S. population, had a serious 
mental illness during the year 2009, alone. In many cases, mental health and substance 
abuse disorders co-occur; an estimated 7.9 million Americans suffered from co-occurring 
mental and substance use disorders in 2014 (Substance Abuse and Mental Health Services 
Administration, 2014). 
 
 Depression is the most common type of mental illness the world over (Ferrari et al., 
2013). It affects over 26% of the U.S. adult population (Kessler, Chiu, Demler, & Walters, 
2005). Depression negatively affects how persons feel, think, and act. It may lead to a 
variety of emotional and physical problems and can decrease a person’s ability to 
function in society (American Psychiatric Association, 2016). Based on its prevalence and 
severity, depression can be categorized as follows (National Institute of Mental Health, 
2015b):  
(a) Major depression: Severe symptoms that interfere with an individual’s 
ability to work, sleep, study, eat, and enjoy life. Episodes may occur once, 
but often several times during an individual’s lifetime. 
 
(b) Persistent depressive disorder: A depressed mood that lasts for at least 
two years. Sufferers may experience episodes of major depression, along 
with periods of less severe symptoms. Forms of depression vary or may 
develop under unique circumstances. These include, but are not limited to: 
 
• Psychotic depression: Serve depression and psychosis, such as 
disturbing false beliefs, delusions, or hallucinations. 
• Postpartum depression: Caused by hormonal and physical changes 
and the overwhelming responsibility of caring for a newborn (Field, 2010). 
• Seasonal affective disorder (SAD): The onset of depression during 
the winter months, when there is less natural sunlight. SAD generally lifts 
during spring and summer (Targum & Rosenthal, 2008).  
• Bipolar disorder: A condition that involves experiences of extreme 
high moods (mania) and extreme low moods (depression). 
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 The impact of depression on American society is quite profound. The most recent 
data available suggests that depression is a leading cause of disability for people age 15-44 
years and is responsible for almost 400 million disability days per year (Colin Mathers, 
Fat, & Boerma, 2008). In addition, depression is strongly interlinked with many chronic 
diseases, including diabetes, cancer, cardiovascular disease, asthma, and obesity and can 
lead to substantially worse health outcomes and reduced quality of life. Persons suffering 
from severe mental disorders are at risk for a 10-25 year life expectancy reduction, mostly 
due to chronic physical medical conditions, such as cardiovascular, respiratory, and 
infectious diseases; diabetes and hypertension; as well as suicide (World Health 
Organization, 2013c). The direct and indirect consequences of depression can be felt well 
beyond the healthcare system. The incremental economic burden of depression (covering 
medical, pharmaceutical, workplace, and suicide-related costs) in the U.S. was evaluated 
at $210.5 billion in 2010. This is a 21.5% increase from 2005 (Greenberg, Fournier, 
Sisitsky, Pike, & Kessler, 2015). 
 
 However, not all forms or occurrences of depression are equally harmful or serious. 
As described above, different types of depression can pose different levels of risk. Many 
individuals who suffer from mild forms of depression may be very unaware of their 
situation and recover without any assistance. Other less severe cases can be effectively 
managed by primary care/family practitioners who deliver over a third of all mental-health 
care services in the U.S. (Wagner et al., 2000; Wells et al., 2000; Williams Jr et al., 2000). 
However, other cases of depression are more harmful and require more advanced and long-
term care (Cuijpers, van Straten, Andersson, & van Oppen, 2008b; Saloheimo et al., 
2016a). 
 
 As mentioned before, primary care is the first line of defense or treatment against 
depression. However, U.S. health infrastructure offers numerous services, ranging from 
inpatient facilities, online support systems, social services, and counseling to treat 
depression and help improve sufferers’ quality of life. These services are provided beyond 
primary care and are designed to meet specific needs and/or populations at higher risk, 
thereby improving their overall quality of life and health status. Thus, we define these as 
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methods of advanced care for depression. Patients in need of these services are therefore 
in need of advanced care for depression. 
 
 Identifying cases of depression that require advanced care may be challenging to 
primary care providers and healthcare team members whose skill sets run broad, rather 
than deep. Training healthcare teams to successfully identify patients with severe 
depression would resolve the problem but is unfeasible, given the cost, effort, and time 
considerations (Force, 2009; Sharp & Lipsky, 2002). Social stigma and ignorance of health 
issues also encourage depression sufferers to downplay their condition, further increasing 
difficulty in detection and assessment (Corrigan, 2004). Second, the need for advanced 
care is also influenced by factors other than disease severity. Factors, such as a patient’s 
background, other clinical conditions, and social and economic status may also contribute 
toward the need for advanced care. However, providers may lack access to these indicators 
for their decision-making. 
 
 While patients shy away from seeking treatment for behavioral health, they often 
present to primary care providers seeking care for other medical conditions. In 2012, 8.6 
million, or 32.3% of all inpatient stays, involved at least one mental disorder or substance 
use disorder diagnosis. Only 1.8 million (6.7%) of these inpatient stays were primarily for 
behavioral health-related challenges (Heslin, Elixhauser, & Steiner, 2012). This implies 
that, while the identification of patients in need of advanced care is challenging, patients 
with such needs were actively presenting for care, and thus, primary care treatment 
facilities are an ideal point of intervention to identify patients in urgent need. Through a 
better understanding of behavioral health issues and patient backgrounds, primary care 
providers can facilitate early and comprehensive treatment of depression and direct patients 
to the care that they need (Muhrer, 2010).  
 
 The need to facilitate early and comprehensive treatment of conditions. such as 
depression, has led to the promotion of integrated care services, which is defined as the 
seamless provision of a mix of complementary social, behavioral, and medical services by 
multiple providers. Integrated service delivery has the potential to improve health 
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outcomes by overcoming misalignments between medical and community systems 
(Kodner & Spreeuwenberg, 2002). Through collaboration and cooperation, integrated 
services address multiple determinants of health and enable the delivery of preventative 
and health-promotion-based interventions (Berwick, Nolan, & Whittington, 2008). In 
treating cases of depression, integrated care services would involve linking patients with 
advanced care needs with referrals to appropriate mental health, social services, and 
financial-aid facilities.  
 
 But how can providers accurately identify patients in need of integrated care for 
depression? While depression is common, not all patients require referrals, and many can 
be effectively treated with minimal effort. Traditionally, providers have used manual 
screening tools to evaluate the presence and severity of depression. However, these are not 
optimal, because they tie-up considerable resources and rely heavily on patient-reported 
outcomes for decision-making (Kerr & Kerr Jr, 2001). These tools utilize only a specific 
subset of clinical and behavioral data for decision making, while other factors, such as the 
patient’s immediate environment/SDH, are ignored. The cost efficiency of screening 
approaches are also questionable (Valenstein, Vijan, Zeber, Boehm, & Buttar, 2001).  
 
 We seek to investigate alternative approaches to improve the detection of patients 
in need of advanced care for depression by leveraging existing knowledge, information 
sources, clinical workflows, and data analytics. 
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2 LITERATURE REVIEW 
 The study and prevention of depression has won significant interest due to its 
widespread nature, potential to cause significant harm, and overall impact on the individual 
and community. Traditionally, clinicians have diagnosed depression and its severity with 
the assistance of self-administered depression screening tools. Widely used screening tools 
(together with scientific literature that they first appeared in) include the Beck Depression 
Scale (Beck, Steer, & Brown, 1996), Center for Epidemiological Studies Depression Scale 
(Radloff, 1977), Geriatric Depression Scale (Brink, Yesavage, & Lum, 1983), the Patient 
Health Questionnaire (PHQ-9) (Gilbody, Richards, Brealey, & Hewitt, 2007), and 
interviewer-administered depression screening tools, such as the Cornell Scale for 
Depression in Dementia (Alexopoulos, Abrams, Young, & Shamoian, 1988) and the 
Hamilton Rating Scale for Depression (HAM-D) (Williams, 2001). These scales are 
significantly influenced by the Diagnostic and Statistical Manual of Mental 
Disorders (DSM), published by the American Psychiatric Association (APA), which offers 
a common language and standard criteria for the classification of mental disorders, 
including depression (American Psychiatric Association, 2013). The DSM has undergone 
significant revisions since the introduction of DSM-I in 1952. The most recent version, 
DSM-5, was released in 2013. 
 
 A detailed analysis of each of the aforementioned tools and their measuring scales 
can be found in table 2.1. 
 
Table 2.1. A study of depression measurement tools 
Beck Depression Scale (BDI)  
Measurement type Self-administered 
Description Consists of 21 multiple-choice questions. One of the most widely 
used psychometric tests for measuring depression severity (Beck 
et al., 1996).  
Measurement scale The BDI scale can distinguish between different subtypes of 
depressive disorders, such as major depression and dysthymia (a 
less severe form of depression). For people who have been 
clinically diagnosed, scores from 0 to 9 represent minimal 
depressive symptoms, 10 to 16 indicate mild depression, 17 to 29 
indicate moderate depression, and scores of 30 to 63 indicate 
severe depression. All scores of 21 or over indicate depression. 
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Patient Health Questionnaire (PHQ-9) 
Measurement type Self-administered 
Description PHQ-9 is a multiple-choice self-report inventory used as 
a screening and diagnostic tool for mental health disorders 
of depression, anxiety, alcohol, eating, and somatoform. 
 
Alternatively, the first two questions of the PHQ-9, also known 
as PHQ-2, are used to identify the degree to which an individual 
has experienced depressed mood and anhedonia over the past two 
weeks. Its purpose is not to establish final diagnosis or to monitor 
depression severity, but rather to screen for depression (Arroll et 
al., 2010). 
Measurement scale Scores of (0-4) no depression, (5-9) mild, (10-14) moderate, (15-
19) moderately severe, and (20-27) severe depression. 
Hamilton Rating Scale for Depression (HAM-D) 
Measurement type Interviewer administered 
Description HAM-D is a multiple-item questionnaire used to provide an 
indication of depression and serve as a guide to evaluate recovery.  
Initially considered the “Gold Standard” for rating depression in 
clinical research, HAM-D has come under criticism, because 
many scale items are poor contributors to the measurement of 
depression severity, while other items have poor inter-rater and 
retest reliability (Bagby, Ryder, Schuller, & Marshall, 2004).  
Measurement scale A score of 0-7 is considered normal. Scores of 20 or higher 
indicate moderate, severe, or very severe depression. Questions 
18-20 may be recorded to give further information about 
depression but are not part of the scale. 
Cornell Scale for Depression in Dementia (CSDD) 
Measurement type Interviewer administered 
Description The Cornell Scale was developed to assess signs and symptoms 
of major depression in patients with dementia (Alexopoulos et al., 
1988). Given that some of these patients may be unreliable, the 
scale is completed using information elicited via two semi-
structured interviews: one for the patient and another for an 
informant (Alexopoulos et al., 1988). 
Measurement scale Each item in the tool is rated on a scale of 0-2 (0=absent, 1=mild 
or intermittent, 2=severe). A combined score <6 indicates the 
absence of significant depressive symptoms. Scores of >=10 
indicates probable major depression. Scores >18 indicate a 
definite major depression.  
Center for Epidemiological Studies-Depression (CESD) 
Measurement type Self-administered 
Description CESD is a 20-item measure that asks persons to rate how often 
they experienced symptoms associated with depression, such as 
restless sleep, poor appetite, and feeling lonely over the past week 
(Radloff, 1977). 
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Measurement scale Scores for each response option on the CESD scale range from 0 
to 3. Patients with an overall score of 16 points or more are 
considered to be suffering from depression (Radloff, 1977). 
 
 As shown above, BDI, PHQ-9, and CESD are self-administered, while CSDD and 
HAM-D are interviewer administered. BDI, PHQ-9, and CESD are influenced by different 
versions of Diagnostic and Statistical Manual criteria for major depressive disorder. BDI 
consists of 21 items, requires approximately five minutes to complete, and must be 
purchased (Pearson Education, 2016). In comparison, PHQ-9 consists of nine items, takes 
about a minute to complete, requires less reading, thanks to its Likert-type scale, and is 
available free of charge. Despite of these differences, there are strong correlations between 
results produced by the two tools (Kung et al., 2013). Each of the tools listed in table 5.1 
is intended for all audiences, with the exception of CSDD, which is designed specifically 
for use by elderly patients with underlying cognitive deficits. All tools consist of somatic, 
cognitive, and affective symptoms. However, HAM-D consists of a larger number of 
somatic symptoms, and relatively few cognitive and affective symptoms (Hamilton, 1960; 
Shafer, 2006; Williams, 2001).  
 
 A majority of these questionnaires are used to quantify depression severity of 
patients already diagnosed as suffering from depression. Their ability to accurately 
determine severity is dependent on patient cooperation. As discussed above, patients who 
are unwilling to pursue treatment due to social stigma or ignorance may not cooperate, 
thereby leading to misdiagnosis. These tools seek to assess the presence and/or severity of 
depression, and not necessarily the need for advanced care for depression. Furthermore, 
administrating these surveys requires additional effort.  
 
 Alternatively, other studies have considered the potential for building clinical 
decision models to detect patients suffering from depression. Such models are 
advantageous, because they leverage existing patient data, can be easily integrated into 
existing clinical workflows, and do not pose an additional burden to the healthcare team. 
Decision models have proven to be successful in predicting illnesses, such as cancer 
(Carneiro, Nascimento, & Bradley, 2015; Fakoor, Ladhak, Nazi, & Huber, 2013; 
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Kasthurirathne et al., 2016; West, Mangiameli, Rampal, & West, 2005), ischemic heart 
disease (Hauskrecht & Fraser, 2000), and leukemia (Corchado, De Paz, Rodríguez, & Bajo, 
2009). A number of studies have already attested the ability to predict depression using 
clinical data. Studies by Trinh et. al. found that EMR data on billing diagnosis, problem 
lists, and antidepressants in medication lists were able to identify cases of depression with 
considerable accuracy (Trinh et al., 2011). In a separate study, regression-based models for 
predicting depression severity and response to treatment using structured diagnosis and 
medication codes and free-text clinical reports were able to predict a future diagnosis of 
depression up to 12 months in advance with considerable accuracy (Huang et al., 2014). 
These studies indicate that clinical data can be used to successfully identify potential cases 
and severity of depression. The type of decision model most suited for detecting specific 
conditions also varies, based on the quality/structure of data at hand and specific 
assumptions made by different algorithms. However, as discussed before, these approaches 
seek to predict the presence and/or severity of depression or other illnesses, rather than the 
ability to identify those in need of advanced care. 
 
 Many clinical factors can influence a patient’s chances of suffering from 
depression. But what factors indicate the need for advanced care as a measure against 
worsening health outcomes and reduced quality of life? Research indicates that depression 
negatively affects outcomes of many chronic illnesses, such as chronic pain (Garbi et al., 
2014) and diabetes (Anderson, Freedland, Clouse, & Lustman, 2001; Katon et al., 2004; 
Lin et al., 2010). Depression also leads to adverse outcomes among those suffering from 
Coronary artery disease (Blumenthal et al., 2003), cancer (Giese-Davis et al., 2011), 
asthma (Eisner, Katz, Lactao, & Iribarren, 2005), stroke (Pohjasvaara, Vataja, Leppävuori, 
Kaste, & Erkinjuntti, 2001), and chronic obstructive pulmonary disease (COPD) (Ng et al., 
2007). Unfortunately, there is no scientific literature that evaluates the impact of depression 
on the outcome of a great many other chronic illnesses. But given the aforementioned 
research, this seems likely. 
 
 However, such factors are not the only determinants to influence the need for 
treatment. Studies show that behavioral and social (socioeconomic, community, and public 
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health-based determinants) may also influence the onset and severity of many diseases, 
including depression, and lead to reduced quality of life and adverse outcomes ((Lorant et 
al., 2003; McPherson & Armstrong, 2006). Behavioral and social determinants affect a 
person’s ability to manage depression, how they react to different situations, and their 
accessibility to proper care. A literature search revealed evidence of a number of 
characteristics that could influence severity of depression and lead to adverse outcomes 
and reduced quality of life (table 2.2). 
 
Table 2.2. Behavioral and social patterns that influence/indicate need of advanced care for 
depression 
Behavior Description 
Eating disorders 
leading to obesity 
and anorexia 
Obesity is significantly associated with depression in women, but 
not in men (Onyike, Crum, Lee, Lyketsos, & Eaton, 2003). 
Furthermore, the comorbidity between anorexia nervosa and major 
depression is likely due to genetic factors that influence the risk for 
both disorders (Wade, Bulik, Neale, & Kendler, 2000). 
Smoking A lifetime history of major depressive disorder is more than double 
in smokers than non-smokers (Aubin, Tilikete, & Barrucand, 
1995). In addition, depressive symptoms and, in some cases, serious 
major depression, may ensue when individuals with a history of 
depression stop smoking (Glassman et al., 1990). 
Evidence of 
childhood abuse 
and household 
dysfunction 
 
Evidence of childhood abuse and household dysfunction, such as 
recurrent physical and emotional abuse, contact sexual abuse, and 
adults with substance abuse problems, as defined by the Adverse 
Childhood Experiences (ACE) study, may lead to depression (Anda 
et al., 2002).  
Substance abuse Addictions are common in people suffering from mental health 
problems. Although substance abuse and mental health disorders, 
such as depression and anxiety, are closely linked, one does not 
directly cause the other (Lehmann, Hubbard, & Martin, 2001). 
Self-harm Self-harm can be a symptom of many psychiatric illnesses, 
including depression (Hawton, Rodham, Evans, & Weatherall, 
2002). 
 
 Other risk factors for increasing the severity of depression and the potential for 
adverse outcomes are heavily associated with social inequalities derived from the 
conditions in which people are born, live, work, and age, and the health systems they may 
access (Lorant et al., 2003; Marmot et al., 2008; Office of Disease Prevention and Health 
Promotion, 2014). The poor and disadvantaged suffer disproportionately, but those in the 
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middle of the social gradient are also affected (Allen, Balfour, Bell, & Marmot, 
2014). Women are twice as likely to suffer from depression than men due to a higher risk 
of first onset (Kessler, 2003). Race is also a significant factor in one’s mental health; large 
epidemiologic surveys (Blazer, Kessler, & McGonagle, 1994; Kesler et al., 2003) report 
that, compared with non-Hispanic whites, African-Americans have lower lifetime rates of 
major depression and equivalent or lower rates of 12-month major depression. Despite this, 
African-Americans are overrepresented in high-need populations, have reduced access to 
mental health services, and receive poorer quality care than whites (General & Services, 
2001). Studies show that in 2009, African-Americans and Hispanic Americans used mental 
health services at about one-half the rate of Caucasian Americans and Asian Americans at 
about one-third the rate (Agency for Healthcare Research and Quality, 2010). Thus, 
factors, such as race, gender, and income group may also help identify populations in 
greater need of treatment for depression. In addition, SDH may also restrict a patient’s 
access to care, further increasing the risk of harm. Factors, such as average household 
income, access to mental health facilities, transportation, crime, and education levels, 
impact one’s potential to obtain treatment for behavioral health needs and thus, the greater 
risk of harm (Aneshensel & Sucoff, 1996).  
 
 Unfortunately, there have been no efforts to systematically categorize social 
determinants that influence the need for treatment and heightened risk. However, there 
have been several efforts to identify and categorize social determinants that affect an 
individual’s overall health and quality of life. Researchers from the Kaiser Family 
Foundation (KFF) proposed a framework that categorizes social determinants into: (a) 
economic stability, (b) neighborhood and physical environment, (c) education, (d) food, 
(e) community and social context, and (f) healthcare system-based factors (Heiman & 
Artiga, 2015). The World Health Organization (WHO) has also proposed a conceptual 
framework for action on social determinants (World Health Organization, 2010). This 
framework categorizes indicators into structural determinants, such as socioeconomic 
position, social class, political context, etc., and intermediary determinants, such as 
behavioral and biological factors and psychosocial factors. Braveman et al. proposed a 
third U.S.-specific framework based on upstream social determinants of health 
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spread across: (a) medical care, (b) behavioral needs, (c) living and working conditions, 
and (e) economic and social opportunities and resources. This framework covers social 
determinants, as well as individual health status and behaviors (Braveman, Egerter, & 
Williams, 2011). However, these are wholly conceptualized frameworks that have seen 
little or no practical implementation/adoption.  
 
 Another point of conflict lies in how to communicate the urgency of care a patient 
requires once he or she is identified as in need of care for depression. As shown in table 
5.1, many traditional depression screening tools use scoring systems to identify the severity 
or type of depression. However, it is unclear how a clinician would operationalize such a 
rating. Clinicians report that these scales do not necessarily translate to “urgency” in terms 
of medical care delivery. In many cases, clinicians identify patients in need of treatment 
and refer them to different departments or clinics most suited to provide specialized mental 
healthcare. In such a scenario, clinicians may be able to recommend that patients in greater 
need of care be seen urgently (i.e., at the next available appointment) or, if the need for 
treatment is not as severe, within a specific timeframe. In most cases, a numeric score, such 
as those provided by traditional screening tools, may do little to influence or assist in care 
management. Therefore, further investigation is necessary to understand how to best 
communicate a sense of urgency for depression care, especially in a context that tries to 
identify the need for treatment in terms of reduced quality of life and the risk of adverse 
outcomes. 
 
 Previous studies that focused on clinical data alone merely indicated whether or not 
a patient was suffering from depression. However, such evaluations fail to understand the 
social and behavioral elements that impact health outcomes and need for treatment. As an 
example, a poor individual living in a remote area with little access to proper health 
facilities is at higher risk and need of care than a well-to-do individual who lives in an 
urban area with excellent access to mental health facilities. While healthcare teams would 
undoubtedly benefit from identifying patients suffering from depression, there is much 
more advantage in quantifying an individual’s risk level and urgency of care, given their 
socioeconomic, clinical, and behavioral status. 
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 We seek to investigate alternative approaches to improve the detection of patients 
in need of advanced care for depression by leveraging existing knowledge, information 
sources, clinical workflows, and data analytics. Our efforts will be broken into three 
incremental aims, as follows, 
• Aim 1: Develop a comprehensive terminology that models the need for advanced 
care for depression using clinical, behavioral, and social determinants of health. 
• Aim 2: Operationalizing the aforesaid terminology, build decision models capable 
of predicting a patient’s need of advanced care for depression using clinical and 
behavioral data. 
• Aim 3: Evaluate whether the inclusion of SDH has a statistically significant impact 
on improving the performance of decision models built using clinical and 
behavioral data. 
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3 METHODOLOGY 
3.1 Aims and Deliverables 
3.1.1 Aim 1 
 Develop a comprehensive terminology that models the need for advanced care for 
depression using clinical, behavioral, and social determinants of health. 
 
3.1.2 Deliverables 
 Based on existing scientific research, we will identify clinical, behavioral, and SDH 
proven to affect the severity, impact, and progression of depression. By mapping these 
determinants to appropriate indicators captured across the healthcare domain, we will 
develop a terminology that models the need for advanced care for depression. 
 
3.1.3 Aim 2 
 Operationalizing the aforesaid terminology, build decision models capable of 
predicting a patient’s need of advanced care for depression using clinical and behavioral 
data. 
 
3.1.4 Deliverables 
(a) A series of decision models capable of predicting the need for advanced care for 
depression using clinical and behavioral features extracted from the 
aforementioned terminology. 
(b) An evaluation of the performance of each decision model. 
 
3.1.5 Aim 3 
 Evaluate whether the inclusion of SDH has a statistically significant impact on 
improving the performance of decision models built using clinical and behavioral data. 
 
3.1.6 Hypothesis 
 The inclusion of SDH has a statistically significant impact on the performance of 
decision models that seek to predict the need for advanced care for depression. 
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3.2 Case Study: Eskenazi Health 
 Eskenazi Health (formerly known as the Wishard Memorial Hospital) is a leading 
health care provider for Central Indiana (Eskenazi Health, 2016). Eskenazi is staffed by 
physicians from the Indiana University School of Medicine (IUSM). The hospital provides 
a wide range of primary and specialty care services within its hospital, various inpatient 
facilities, and 11 community health centers. Eskenazi Health is widely known for its 
nationally recognized programs, such as Midtown Community Mental Health and the 
Primary Care-Center of Excellence in Women’s Health; it is the sponsoring hospital for 
Indianapolis emergency medical services (EMS). The hospital’s mission is to advocate, 
care, teach, and serve, with emphasis on the vulnerable populations of Marion County, 
Indiana (Eskenazi Health, 2016). Patients presenting at Eskenazi may undergo inpatient or 
outpatient care, or be referred to other specialist care centers, such as Midtown Community 
Mental Health, which serves all behavioral health needs. Like many other hospitals 
nationwide, Eskenazi would benefit from better approaches to identifying patients 
suffering from depression and refer these patients to appropriate care facilities.  
 
 I propose to leverage clinical and behavioral patient data, as well as patient and 
aggregate-level SDH, such as aggregate geo-coded community, socioeconomic, and public 
health data extracted from Eskenazi Health and other state and not-for-profit organizations 
to build clinical-decision models to identify patients’ mental health needs. 
 
3.3 Aim 1 
3.3.1 Proposed approach 
 In our literature review, we presented a strong justification for the role of clinical, 
behavioral, and patient and aggregate-level SDH in predicting the need for advanced care 
for depression. Our study identified a number of clinical and behavioral factors that were 
strongly linked to the need for advanced care. We also presented the KFF framework, a 
conceptual framework for modeling aggregate-level SDH that had won significant support 
but showed little evidence of implementation. In this phase of the study, we will build a 
comprehensive terminology representing advanced care needs for depression using 
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existing clinical, behavioral, and SDH identified via the KFF framework and other 
knowledge sources.  
 
 But how can data elements presented as abstract concepts be mapped to biomedical 
data and/or indicators collected by the Eskenazi Health system and other organizations?  
 
3.3.2 Operationalizing abstract concepts against the healthcare continuum 
• Clinical and behavioral data 
Eskenazi Health is a participating organization of the Indiana Health 
Information Exchange (IHIE), a large, statewide Health Information Exchange 
(HIE) (McDonald et al., 2005). Since its inception in 2004, IHIE has grown to 
cover 93 out of 114 hospitals and more than 14,000 physicians statewide 
(Overhage, 2013). Due to its participation in IHIE, medical information of any 
Eskenazi patient seeking treatment at any of these 93 hospitals can be extracted 
via IHIE. IHIE stores clinical diagnosis in structured format using International 
Classification of Disease version 9 (ICD-9) codes and other relevant 
terminologies. However, certain clinical conditions and diagnoses are not 
limited to a single code and may be classified across multiple clinical codes 
spread across different terminologies. How can we identify all code sets for 
specific conditions and diagnoses of interest? We propose to use the UMLS 
Metathesaurus, a multi-lingual thesaurus that contains millions of biomedical 
concepts, synonymous names, and relationships across 199 medical dictionaries 
using information obtained from existing scientific literature (U.S. National 
Library of Medicine, 2013) to consolidate larger code sets into actionable 
concepts. 
 
• Social determinants of health 
In our literature search, we researched frameworks for modeling aggregate-
level SDH. As a preliminary study, we sought to understand how these 
conceptual frameworks could be implemented using indicators collected by the 
Polis Center, a reputed research organization that seeks to understand the 
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communities that people live in, and the Indiana State Department of Health. 
We found that, while many of the conceptual categories identified via the KFF 
framework could be populated using existing data, several, such as vocational 
training, social integration, etc., could not. Thus, we sought suitable proxies to 
represent these (table 3.1).   
 
Table 3.1. KFF conceptual indicators, together with practical measures that represent them 
KFF category 
types Conceptual indicators  
Indicators 
Economic 
Stability 
  
  
  
  
  
Employment Number of employed, unemployment 
rates, and numbers 
Income, expenses, debit, 
medical bills, support 
% of households spending more than 30% 
on housing, GINI, median family income, 
median household families w/children 
<18 in poverty, poverty rate, population 
with incomes below 125% of poverty 
level, population with incomes below 
185% of poverty level, count x per-capita 
income/acres  
Neighborhood 
and Physical 
Environment 
  
  
  
  
  
Housing Residential building permits, owner-
occupied 
Transportation % of trips not in auto 
Safety Juvenile crime, property crime index, 
violent crime index, collisions per 1000 
pop 
Parks and playgrounds Park/greenway/playground within 10 min 
walk from home 
Walkability Intersections/square mile, %  
neighborhoods have paved walkways 
Education 
  
   
  
  
Literacy and 
language 
% of all households with household 
language of English 
Early childhood 
education 
Pct PTQ 3-4 childcares/all childcares, 
births to mothers with less than high 
school ed, child-care utilization (PTQ), 
children under age 6 w/working parents, 
passing rates IREAD–Grade 3, % of 
family households with school-aged 
children within 1 mile of an A or B school 
by school type (trade public; no private or 
charter)  
Higher education,  
vocational training 
Enrolled in college, attainment (bach 
degree or higher) 
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 Other patient-level SDH may be extracted from clinical data. We propose to 
develop a terminology that models advanced care needs for depression using the 
aforementioned clinical, behavioral, and SDH. Our terminology will be designed using 
formative principles (Coltman, Devinney, Midgley, & Venaik, 2008) in order to reduce 
information redundancy for better performance. While we will endeavor to remove 
redundant or irrelevant indicators from the terminology, not all redundancies may be 
identified during development. However, such features will continue to be removed if they 
are identified during decision modeling undertaken as part of aim 2.  
 
3.4 Aim 2 
3.4.1 The problem domain 
 Currently, patients presenting at Eskenazi with advanced care needs may be 
referred to mental health services by clinicians or other healthcare team members. Referrals 
are made via multiple sources. Physicians may refer patients using the referral system in 
the Gopher G3 medical software (Duke et al., 2014). Alternatively, other members of the 
healthcare team may use the eClinicalWorks Care coordination for Medical Records 
(CCMR) tool (eClinicalWorks, 2016) to make referrals. Information, such as type of care 
required (alcoholism, substance abuse, depression, etc.) and urgency of care (next 
Food 
  
Hunger Food stamp recipients (SNAP), cash 
public assistance, % of population within 
1 mile of a supermarket/large grocery 
store  
Access to healthy options % of population within 1 mile of a 
supermarket/large grocery store  
Community 
and social 
context 
  
  
  
Social integration  ? 
Support systems % neighbors are willing to help 
Community engagement Registered voters, voter/registered 
Discrimination  ? 
Healthcare 
system 
  
  
  
Health coverage Population without health insurance 
Provider availability  ? 
Provider linguistic and 
cultural competency 
Percent of all households with household 
language of English 
Quality of care  % who feel accepted/respected by their 
current healthcare provider 
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available, within 3 months, within 1 month, within 2 weeks, and emergency, etc.) may also 
be documented. All mental health needs identified at Eskenazi Health are referred to the 
Midtown Community Mental Health Center, which provides comprehensive inpatient and 
outpatient services for all types of emotional and behavioral health problems, including 
depression.  
 
 We propose to improve the referral process by enabling better detection of patients 
in need of advanced care for depression by developing decision models using clinical and 
behavioral indicators extracted from the depression terminology developed during aim 1. 
 
3.4.2 Selection of patients for inclusion 
 We will identify a subset of adult patients (over 18 years of age) who have received 
at least one outpatient visit for inclusion in our study. This patient sample will include 
patients who were referred for advanced care for depression, as well as those who were 
not.  
 
3.4.3 Clinical and behavioral data extraction 
 Clinical and behavioral data of each patient will be extracted from the IHIE using 
the terminology developed under aim 1. However, given that Eskenazi systems became 
operational in 2010, will IHIE contain adequate amounts of data for our study? We 
performed a feasibility study on IHIE data to assess the availability of the aforementioned 
clinical and behavioral data from patients receiving care at Eskenazi Health. Given 
technical limitations, our analysis was limited to a subset of relevant ICD-9 codes. 
 
Table 3.2 Availability of relevant clinical and behavioral data in IHIE 
Condition/behavior ICD9 code/categories used Approximate 
no. of 
patients* 
Diabetes ICD9:250 Diabetes mellitus 833 
Asthma ICD9:493 Asthma 54553 
 
Chronic obstructive 
pulmonary disease and 
allied conditions 
ICD9 (490-496) Chronic obstructive 
pulmonary disease and allied conditions 
 
94399 
 19 
Stroke ICD9:434.91 Cerebral artery occlusion, 
unspecified, with cerebral infarction 
3554 
Eating disorders ICD9:307.5 Other and unspecified 
disorders of eating 
ICD9:278 Overweight, obesity and other 
hyperalimentation 
231 
 
46,055 
 
Tobacco abuse ICD9:15.82 History of tobacco use 6348 
Alcohol abuse ICD9:305.00 Alcohol abuse, unspecified 
drinking behavior 
41052 
 
Substance abuse ICD9:305.90 Other, mixed, or unspecified 
drug abuse, unspecified 
8845 
Self-harming behaviors ICD9:E958 Suicide and self-inflicted 
injury by other and unspecified means 
426 
History of child abuse ICD9:V15.41 Personal history of physical 
abuse 
205 
 
3.4.4 Social determinant data extraction 
 Patient-level SDH will be extracted from clinical data, while geo-coded aggregate-
level data covering the domains of education, neighborhood and environment, 
employment, health levels, and access to various services/facilities will be obtained from 
the Polis Center (Polis Center, 2018), a not-for-profit that seeks to understand the 
communities that people live in. Given that Eskenazi Health focuses on the underserved 
communities of Marion Country, we will only obtain social indicators reported for this 
county. A preliminary query to these institutions resulted in confirmation that the aforesaid 
datasets are available and could be shared for use (table 3.2). These data were collected 
between 2010-2014 and were available at census-tract level. 
 
3.4.5 Clinical decision modeling 
 Clinical, behavioral, and SDH will be merged into a master dataset. Each row of 
the dataset will represent a specific patient, while each column will represent various 
clinical, behavioral, and SDH indicators. Each patient will also be assigned a Boolean 
outcome variable based on whether or not they have been referred for depression treatment.  
 
3.4.6 Data pre-processing 
 We will perform appropriate data pre-processing on the master dataset to determine 
the best approaches to identify patients in need of advanced care for depression. To ensure 
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reproducibility, ease of adoption, and the utilization of existing knowledge and resources, 
data pre-processing and decision-model building will be performed using publicly 
available tools, algorithms, and programming languages. 
 
 We anticipate that the master dataset will consist of a considerable number of 
attributes, or “features.” However, not all features may contribute equally towards the 
accuracy of the models. Many features may be redundant, irrelevant, or lack adequate 
variance to contribute towards predicting the outcomes at-hand. Using such data may lead 
to overfitting and reduce accuracy (Hawkins, 2004). Therefore, we will consider multiple 
approaches to filter the master data set and identify only the most important/relevant 
features for decision-model building. Using smaller feature sets enables: (a) the 
simplification of models, making them easily interpretable by researchers, (b) shorter 
training times, and (c) enhanced generalization via the prevention of over-fitting (Jain & 
Zongker, 1997; Peng, Long, & Ding, 2005).  
 
 We will consider the following approaches for identifying the most relevant 
features: 
• Feature selection: The process of identifying a subset of the most 
relevant features with the least loss of information. Widely known methods 
of feature selection include information gain, also referred to as Kullback-
Leibler divergence (Polani, 2013). 
• Feature engineering: The process of combining existing features 
into composite features that better represent nuances of the dataset under 
test, resulting in improved model accuracy on unseen data (Turner, Wolf, 
Fuggetta, & Lavazza, 1998).  
 
 We will consider multiple feature engineering approaches, including principle 
component analysis (PCA) (Jolliffe, 2002), as well as the feasibility of adopting 
comorbidity indexes to reduce the dimensionality of the feature set. Indexes, such as the 
Charlson Comorbidity Index, which is used to predict one-year mortality for patients who 
may suffer from a total of 22 different comorbid conditions, such as heart disease, AIDS, 
and cancer (Charlson, Pompei, Ales, & MacKenzie, 1987), and the Elixhauser Comorbidity 
Measure, an alternative measure developed based on a list of 30 comorbidities linked to 
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the ICD-9-CM coding manual, may be considered for evaluation (Sharabiani, Aylin, & 
Bottle, 2012). 
 
3.4.7 Decision-model building  
 Decision models may be built using two different approaches: (a) classification or 
supervised algorithms that require training data to group similar instances based on pre-
tagged training data, and (b) clustering or unsupervised algorithms that do not require 
training data, which group similar instances based on available features. Given the 
reliability of classification algorithms and the availability of training data (i.e., a “gold 
standard,” as indicated by the presence of an outcome variable, “was the patient referred 
for depression care or not?”), we will attempt to build appropriate decision models using 
classification algorithms. 
 
 We will randomly separate the master dataset into training and test datasets. 
Decision models may be trained using a number of potential algorithms representing the 
spectrum of existing classification approaches: 
• Regression-based algorithms: Examples: Linear and logistic 
regression. 
• Instance-based algorithms: A family of learning algorithms that 
perform lazy learning by comparing new problem instances with instances 
seen in training (Brighton & Mellish, 2002). Examples: k-Nearest Neighbor 
(KNN) algorithm. 
• Decision trees: A class of learning algorithms that map observations 
about an item to conclusions about the item’s target value (Quinlan, 1986). 
Examples: C4.5 and Random Forrest. 
• Bayesian networks: A probabilistic graphical model that represents 
a set of random variables and their conditional dependencies via a directed 
acyclic graph (Nielsen & Jensen, 2009). Examples: Naive Bayes. 
 
Dependent and independent variables for our study are as follows: 
• Dependent variables: Is the patient in need of advanced care for 
depression? 
• Independent variables: The clinical, behavioral, and SDH selected 
for decision-model building.  
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3.4.8 Evaluation 
 Each decision model will be tested with holdout data to evaluate its accuracy. For 
each patient in the holdout test dataset, the decision model will predict a binary outcome 
(i.e., does this patient need advanced care for depression, or not) and the predictive 
probability for this decision. These results would be used to calculate a number of 
performance metrics, such as Positive Predictive Value (PPV), sensitivity, specificity, 
overall accuracy, and area under the ROC curve.   
 
3.5 Aim 3 
 We seek to determine if the inclusion of patient and aggregate-level SDH has a 
statistically significant impact on the accuracy of the decision models. In the previous 
analysis, we built decision models using a master feature set comprising clinical and 
behavioral features (model A). To evaluate the contribution of SDH in this evaluation, we 
will train additional models that include SDH (model B) and evaluate their performances 
with model A. The two decision models will be tested using test holdout data and be 
compared based on their overall accuracy. Figure 3.1 represents the potential decision-
model building process for aims 2 and 3. 
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Figure 3.1. The study approach, from the preparation of the master dataset to data pre-
processing, decision model building, testing, and outcome evaluation. 
 
3.5.1 Evaluation 
 In aim 2 above, we described challenges in assessing decision model performance 
and how they may be evaluated. Evaluation for aim 3 will be similar to that prescribed 
under aim 2. We will calculate the overall accuracy measure and 95% confidence intervals 
for models A and B. The two models will be compared with one another based on their 
accuracy and 95% confidence interval, which will be used to determine if there is a 
statistically significant advantage in using SDH to predict the need for advanced care for 
depression (Figure 3.2). 
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Figure 3.2 Comparison of the performance of decision models built using (a) clinical, 
behavioral and SDH data, and (b) clinical and behavioral data only 
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4 AIM 1: DEVELOPMENT OF A KNOWLEDGE-DRIVEN MEDICAL 
TERMINOLOGY FOR BIG DATA-BASED DECISION MODELING FOR NEED 
OF TREATMENT FOR DEPRESSION 
4.1 Introduction 
 Depression has a profound effect on society (Ferrari et al., 2013). It is the most 
common mental illness, hindering the emotions, thoughts, and behaviors of over 350 
million people worldwide (Mathers, Boerma, & Fat, 2008; World Health Organization, 
2013a). Depression is also strongly correlated with many chronic diseases, including 
diabetes (Greenberg et al., 2015), cancer (National Institute of Mental Health, 2015a), 
cardiovascular disease, asthma, and obesity, and can lead to poor health outcomes and 
reduced quality of life (Goldberg, 2011). Persons suffering from severe mental disorders 
are at risk of a 10-25 year life expectancy reduction, mostly due to chronic physical medical 
conditions, such as cardiovascular, respiratory, and infectious diseases; diabetes; 
hypertension; and suicide (World Health Organization, 2013b). Studies show that 
depression is also a leading cause of disability for Americans age 15-44 years, and is 
responsible for almost 400 million disability days per year (Mathers, 2008). The 
incremental economic burden of depression (covering medical, pharmaceutical, 
workplace, and suicide-related costs) in the U.S. was evaluated at $210.5 billion in 2010, 
a 21.5% increase from 2005 (Greenberg et al., 2015). 
 
4.1.1 Types of depression 
 Depression can be grouped into two primary categories: (a) Major 
depression: Severe symptoms that interfere with an individual’s ability to work, sleep, 
study, eat, and enjoy life. Episodes may occur once, but often several times during an 
individual’s lifetime; (b) Persistent depressive disorder: A depressed mood that lasts at 
least two years (Bressert, 2017). A sufferer may have episodes of major depression, along 
with periods of less severe symptoms, but symptoms must last for up to two years. Forms 
of persistent depressive disorder may vary or may develop under unique circumstances. 
These include psychotic depression, postpartum depression, Seasonal Affective Disorder 
(SAD), and bipolar disorder (National Institute of Mental Health, 2015a). 
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 As a heterogeneous disease (Goldberg, 2011), not all instances of depression are 
equally harmful or serious. Individuals who suffer from mild forms of depression may be 
unaware of their situation and recover without assistance. Yet others may be satisfactorily 
treated in primary care (Cape, Whittington, Buszewicz, Wallace, & Underwood, 2010). 
However, other cases of depression pose greater risk and require more advanced and long-
term care (Cuijpers et al., 2008b; Saloheimo et al., 2016a). Studies show that depression 
severity and need for care may also be influenced by a wide variety of factors beyond 
clinical and behavioral indicators. Socioeconomic conditions, such as education, physical 
environment, feelings of safety, and access to various facilities/services, may also influence 
the onset and severity of depression, leading to reduced quality of life and adverse 
outcomes (Lorant et al., 2003; McPherson & Armstrong, 2006; Santos, Kawamura, & 
Kassouf, 2012). Socioeconomic conditions may also correlate with a person’s ability to 
manage depression, how they react to different situations, and their accessibility to proper 
care. Thus, such determinants may be invaluable in determining need of care for patients 
suffering from depression. 
 
 Given that depression may be triggered by many conditions and aggravated by 
various social determinants, it is difficult for healthcare providers to identify patients in 
need of treatment. Traditionally, providers have used manual screening tools, such as the 
Patient Health Questionnaire (PHQ-9) (Gilbody et al., 2007), the Cornell Scale for 
Depression in Dementia (Alexopoulos et al., 1988), and the Hamilton Rating Scale for 
Depression (HAM-D) (Williams, 2001), to evaluate the presence and severity of 
depression. However, such tools pose a number of limitations: (a) they encumber 
considerable resources, (b) rely heavily on a narrow set of patient reported outcomes that 
may be impacted by fear of stigma for decision-making (Conner et al., 2010; Kerr & Kerr 
Jr, 2001), and (c) ignore a greater number of clinical and socioeconomic determinants that 
may influence the onset and severity of depression. 
 
 Recent studies demonstrate significant potential for Artificial Intelligence 
(AI), which leverages the concepts of machine learning, Natural Language Processing 
(NLP), and knowledge representation for informed medical decision making using clinical, 
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social, and behavioral data (Kasthurirathne, Vest, Menachemi, Halverson, & Grannis, 
2017). Given that the onset and severity of depression may be influenced by a variety of 
clinical and social determinants, predictive models may help overburdened caregivers 
identify patients in need of care for depression. They improve the accuracy and efficiency 
of screening by leveraging existing clinical data and may be easily integrated into existing 
healthcare delivery systems. 
 
 But which clinical, behavioral, and social determinants are most relevant for 
inclusion in such a study? Traditionally, medical terminologies have provided inputs into 
predictive models (Kasthurirathne, Dixon, et al., 2017a) for various clinical outcomes 
(Kasthurirathne, Dixon, et al., 2017b). For example, terminologies, such as Berman’s 
Tumor Taxonomy (Berman, 2004), have been used to predict occurrences of cancer with 
significant success (Kasthurirathne, Dixon, et al., 2017b). Given the diverse nature of 
depression’s presenting symptoms, there is no single terminology that represents the full 
range of clinical, behavioral, and socio-economic determinants that influence the risk of 
depression. However, we hypothesize that concepts of relevance do exist and are 
fragmented across multiple medical terminologies. Given the significant cost and manual 
effort required to build a condition-specific medical terminology from scratch (Hinz et al., 
2010), it is more cost efficient to model such a terminology using medical concepts learned 
from existing knowledge and terminology sources.  
 
 We present a novel, automated approach that combines existing knowledge and 
terminology systems to compose a knowledge-driven terminology that, coupled with 
machine-learning approaches, can be used to identify the need of treatment for depression.  
 
4.2 Materials and methods 
 We extracted relevant concepts from the Unified Medical Language System 
(UMLS) Metathesaurus, a multi-lingual thesaurus that contains millions of biomedical 
concepts, synonymous names, and relationships across 199 medical dictionaries using 
information obtained from existing scientific literature (U.S. National Library of Medicine, 
2013).  
 28 
 
 We performed a literature search using Ovid Medline to identify publications on 
depression and its treatment. Due to the terms of use restricting extraction and processing 
of entire manuscripts, we extracted only plaintext abstracts for each identified publication. 
We used Metamap, a Natural Language Processing (NLP)-based tool to map these abstracts 
against the UMLS Metathesaurus, and thus identify clinical concepts of relevance from 
199 medical dictionaries that are part of the UML Metathesaurus (Aronson & Lang, 2010). 
We used term frequency (tf) to identify the most significant concepts from the abstracts. 
Next, we removed all concepts that belonged to the semantic categories animal (anim), bird 
(bird), mammal (mamm), and fish (fish) on the grounds that they were irrelevant for 
representing human health, and all concepts that belonged to the semantic categories cell 
component (celc), cell function (celf), cell (cell), nucleotide sequence (nusq), as they 
referred to cell-level functions that were unrelated to predicting the need of care for 
depression. We also replaced a number of country names with a generic country tag, race 
names with a generic race concept, and non-medical occupations with a single-occupation 
concept. 
 
 While the influence of aggregate-level social determinants on depression and 
overall healthcare delivery is widely known, existing vocabularies are patient-centric and 
not designed to cover aggregate-level social determinants of health. Thus, we anticipated 
that the 199 dictionaries included in the UMLS Metathesaurus would not help to identify 
such concepts. We sought alternative approaches to identify aggregate-level social 
determinants of health. Researchers from the Kaiser Family Foundation (KFF) proposed a 
framework that categorizes social determinants of health into subcategories representing 
an individual’s socio-economic environment: (a) economic stability, (b) neighborhood and 
physical environment, (c) education, (d) food, (e) community and social context, and (f) 
healthcare system-based factors (Heiman & Artiga, 2015). Given the lack of adequate 
concepts to model these terms, we used a pre-coordination approach to represent said 
concepts without our system. These concepts were compiled into a terminology using the 
Web Ontology Language (OWL) V2 (Motik et al., 2009), a semantic web language that is 
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widely used to represent ontologies. A flowchart presenting our complete approach can be 
seen in figure 4.1. 
 
 
Figure 4.1 The depression terminology development approach 
 
4.2.1 Terminology assessment 
 Researchers have proposed a number of approaches for evaluating terminologies 
(Brank, Grobelnik, & Mladenić, 2005). However, many of these approaches were 
challenging: (a) data-driven evaluation approaches call for terminology evaluation by 
comparing them to existing knowledge sources (usually a collection of textual documents) 
on the problem domain. However, we cannot adopt such an evaluation approach, as the 
existing body of scientific research was already used to develop our terminology; (b) 
taxonomic and semantic evaluation approaches call for analysis of the structural fit of 
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concepts (Brewster, Alani, Dasmahapatra, & Wilks, 2004). However, we cannot adopt this 
approach, as we rely on the UMLS Metathesaurus as the gold standard for extracting 
taxonomic and semantic relationships. Thus, the taxonomic and structural accuracy of our 
terminology would be dependent on the accuracy of the UMLS Metathesaurus; (c) expert-
led human evaluation of the depression terminology is also infeasible, given the wide range 
of concepts representing a large number of expert domains.  
 
 As an alternative, we will evaluate the completeness of the depression terminology 
by comparing it against other existing depression screening tools, and thus, assess its 
overall coverage and suitability. 
 
4.3 Results 
 Our literature search identified a total of 3,890 publications published in the English 
language over the last 10 years (table 4.1).  
 
Table 4.1. Literature search to identify factors indicating need of treatment for depression 
(exp = expression) 
1 exp Depression/or *Long-Term Synaptic Depression/or exp Cortical 
Spreading Depression/or exp Depression, Postpartum/or exp 
Depression, Chemical/or depression.mp. 
335,211 
2 exp Depressive Disorder/or exp Seasonal Affective Disorder/ 97,664 
3 exp Bipolar Disorder/ 36,536 
4  1 or 2 or 3 386,130 
5 exp Emergency Medical Services/or exp Palliative Care/ or advanced 
care.mp. 
165,171 
6 exp Hospitalization/or exp Hospitals, Psychiatric/or inpatient care.mp. 
or exp Psychiatric Department, Hospital/ 
224,129 
7 5 or 6 371,706 
8 4 and 7 11,277 
9 limit 8 to (English language and last 10 years) 4,046 
10 remove duplicates from 9 3,890 
 
 Metamap analysis of the abstracts of these publications identified a total of 17,019 
unique concepts from the UMLS Metathesaurus. By assessing frequency of these concepts, 
we selected a frequency cutoff threshold of six or more occurrences, which left us with 
7,402 concepts for further study. These concepts presented a wide variety of genetic, 
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clinical, demographic, behavioral, and patient-level SDH features that impacted the onset 
and severity of depression. Next, the concepts were grouped into a hierarchy based on their 
semantic type. Table 4.2 presents the number of concepts included under each parent 
concept of our terminology. For a more detailed breakdown, see Appendix 9.1.  
 
Table 4.2. Frequency of UMLS concepts included under each parent concept 
Type No. of concepts 
Activities and behaviors 389 
Anatomy 204 
Chemicals and drugs 604 
Concepts and ideas 2,499 
Disorders 1,250 
Genes and molecular sequences 194 
Geographic areas 162 
Living beings 415 
Objects 213 
Occupations 108 
Organizations 171 
Phenomena 146 
Procedures 1,047 
 
 These 7,402 concepts, representing clinical and behavioral indicators, were mapped 
to a total of 45,297 other UMLS concepts from 70 different terminologies of the UMLS 
Metathesaurus (Appendix 9.2). Assessment of SDH, defined by the Kaiser Family 
Foundation framework, led to the creation of 56 additional concepts that represented 
aggregate-level SDH. These concepts were grouped under six different parent concepts 
(Appendix 9.3).  
 
 Our efforts resulted in the development of a valid OWL-based terminology. We 
evaluated the terminology by comparing it against other conventional depression screening 
tools. Our analysis indicated complete or high coverage of each of these tools (table 4.3).  
 
Table 4.3. Comparison of terms in depression terminology against other existing 
depression screening tools 
Depression screening 
tool 
Feature coverage Features missing from the 
depression terminology 
PHQ-9 scale  
(9 questions) 
9/9 (100%) None 
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HAM-D scale  
(21 questions) 
18/21 (85.7%) Hypochondriasis 
Diurnal variation 
Paranoid symptoms 
Cornell Scale for 
Depression and 
Dementia (19 
questions) 
Mood-related signs: 4/4 (100%) 
Behavioral disturbance: 4/4 
(100%) 
Physical signs: 3/3 (100%)) 
Cyclic functions: 2/4 (50%) 
Ideational disturbance: 4/4 
(100%) 
Early morning awakening 
Diurnal variation 
 
Beck Depression Scale  
(21 questions) 
21/21 (100%) None 
Center for 
Epidemiological 
Studies-Depression 
scale  
(21 questions) 
21/21 (100%) None 
 
4.4 Discussion 
 Our efforts resulted in the development of a well-defined terminology that covered 
a wide variety of clinical, behavioral, genomic, as well as patient- and aggregate-level SDH 
that influence the health of an individual suffering from depression. The depression 
terminology included a total of 7,402 UMLS concepts mapped to 45,297 additional 
concepts from across 70 other UMLS terminologies, as well as 56 additional concepts that 
represented aggregate-level SDH developed based on the KFF framework. These concepts, 
while unmapped to the UMLS Metathesaurus, represented a wide range of indicators 
representative of an individual’s role in society. As presented in table 4.3, concepts in the 
depression terminology covered a majority of indicators present in existing depression 
screening tools. The depression terminology was developed using expert knowledge 
automatically extracted from peer-reviewed scientific literature. Thus, our approach does 
not require time- and cost-intensive human experts for concept identification.  
 
 Our efforts were impacted by the lack of terminologies that represented aggregate-
level SDH, which prevented our ability to identify their impact on depression from 
scientific literature. Our terminology also included many concepts that, though not 
indicative of the need for depression, would be used as responses or measures used to 
quantify other concepts. In contrast to existing screening tools and risk models, our 
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terminology included a total of 194 concepts on genes and molecular sequences. We 
believe that these are highly relevant, given the significance of genes on the onset and 
severity of depression, as well as calls to improve the use of genetics in managing 
depression (Hyman, 2014).  
 
 While our terminology represents a wide range of features indicating risk of 
depression, its use is dependent on the quality of data at hand. For example, we recognize 
that not all concepts identified in our terminology may be reported in adequate prevalence 
for use in machine learning. Thus, implementation of the terminology for machine learning 
purposes may change based on the healthcare setting. In some instances, we may be 
required to use different groupings of concepts in order to better represent the dataset being 
used. However, this should be relatively easy, given the well-defined UMLS concept 
mappings included in the terminology.  
 
 We identified several limitations in our approach. Due to the nature of our approach 
and the intended application to machine learning, we anticipate that our terminology 
maximizes capturing all true positives, and thus, may contain a number of false positives. 
We recognize that while all concepts may be relevant for every use case, for example, 
concepts, such as country names and cities included under the “geographic areas” parent 
concept, may be irrelevant. The applicability of other clinical data may also change based 
on availability of data. However, such concepts could be easily removed from machine-
learning models using feature selection approaches (Guyon & Elisseeff, 2003). Thus, we 
present that our terminology presents “fitness for purpose” for use in machine learning. 
Second, we sought to identify a subset of UMLS concepts that could model an individual’s 
risk of depression. Thus, our terminology reflects any weaknesses or limitations in the 
terminologies that are part of the UMLS Metathesaurus. Finally, our terminology leverages 
a social determinants model intended to represent overall health status, and not specifically 
social determinants influencing depression.  
 
 We believe that the approach used to develop the depression terminology presents 
a convenient, low-cost effort that requires minimal human effort and expert intervention. 
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Our approach may also be replicated for healthcare challenges other than depression and 
will be invaluable in leveraging existing knowledge and terminologies with machine 
learning for improving automated surveillance and prediction. 
 
 Future steps include an application-driven evaluation of the terminology by 
populating it with clinicals obtained from the Indiana Network for Patient Care (INPC) 
(McDonald et al., 2005), and social determinants of health obtained from the SAVI 
Community Information System, the nation’s largest provider of spatially-enabled socio-
economic determinants (Bodenhamer, Colbert, Comer, & Kandris, 2011) and using it to 
predict the need for advanced care for depression. 
 
4.5 Conclusion 
 We developed a well-defined terminology that encompasses a wide variety of 
clinical, behavioral, genomic, as well as patient and aggregate-level social determinants 
that influence the health of an individual suffering from depression. Given the high 
dimensionality of this terminology, we hypothesize that our terminology would be highly 
suited for application in big data-based machine learning efforts to inform depression care. 
Our terminology would inform feature extraction from big datasets that could then be 
filtered down for machine learning via various feature selection approaches. Additionally, 
our methods are replicable and may be duplicated to identify features across a range of 
other healthcare conditions with low-cost and human expertise requirements. However, 
features of relevance may change, based on the completeness and accuracy of the dataset 
to which the terminology is applied. 
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5 AIM 2: PREDICTING NEED OF ADVANCED CARE FOR DEPRESSION USING 
CLINICAL, BEHAVIORAL, AND DEMOGRAPHIC DATA AND MACHINE-
LEARNING APPROACHES 
5.1 Introduction 
 Depression is the most commonly occurring mental illness the world over (World 
Health Organization, 2012). It negatively affects how up to 350 million persons worldwide 
think, feel, and interact (American Psychiatric Association, 2016).  
 
 Depression poses significant health and economic burdens across both the 
individual and community (Lépine & Briley, 2011). Studies present a strong comorbidity 
between mental health and medical conditions (Goodell, Druss, Walker, & Mat, 2011). 
Depression is highly prevalent across patients suffering from chronic conditions, such as 
chronic obstructive pulmonary disease, chronic heart failure (Yohannes, Willgoss, 
Baldwin, & Connolly, 2010), and type 2 diabetes (Nouwen et al., 2010). Such patients may 
suffer up to a 10-25 year reduction in life expectancy due to worsening health conditions 
and suicide (Hawton, i Comabella, Haw, & Saunders, 2013; World Health Organization, 
2016). Depression is also a leading cause of disability for Americans age 15-44 years and 
is responsible for up to 400 million disability days per year (Mathers et al., 2008). The 
incremental economic burden of depression covering medical, pharmaceutical, workplace, 
and suicide-related costs in the U.S. was evaluated at $210.5 billion in 2010, a 21.5% 
increase from 2005 (Greenberg et al., 2015). 
 
 Many healthcare systems screen patients for depression using tools, such as the 
Beck Depression Scale (Beck et al., 1996), the Patient Health Questionnaire (PHQ-9) 
(Gilbody et al., 2007), the Cornell Scale for Depression in Dementia (Alexopoulos et al., 
1988), and the Hamilton Rating |Scale for Depression (HAM-D) (Williams, 2001). 
However, there is a disjoint between patients who suffer from depression and patients 
acutely in need of care for depression. Despite the high prevalence of depression, most 
forms of depression are relatively mild and may be treated with medication. Only some 
forms of depression are far more severe and require advanced care above and beyond that 
provided by primary care providers (Cuijpers, van Straten, Andersson, & van Oppen, 
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2008a; Saloheimo et al., 2016b). Additionally, traditional depression screening approaches 
may increase the risk of over-diagnosis and over-treatment of depression across community 
and primary care settings (Dowrick & Frances, 2013; Mojtabai, 2013; Mojtabai & Olfson, 
2011) without contributing to better mental health (Thombs, Ziegelstein, Roseman, Kloda, 
& Ioannidis, 2014). Recent studies have questioned the benefits of routine screening 
(Gilbody, Sheldon, & Wessely, 2006; Thombs et al., 2012) and questioned United States 
Preventive Services Task Force (USPSTF) recommendations to screen adults for 
depression in primary care settings when staff-assisted depression management programs 
are available (Thombs et al., 2014). 
 
 Due to such limitations, it is more clinically appropriate to develop screening 
approaches to identify patients suffering from serve cases of depression, patients who 
cannot be treated at primary care alone, and patients who would suffer from worsening 
health conditions unless they are provided with specialized care. Previously, we performed 
knowledge-based terminology extraction of the UMLS Metathesaurus (Bodenreider, 2004) 
to develop a depression terminology that represented a wide range of clinical, behavioral, 
and socio-economic determinants that impacted an individual’s risk of suffering from 
depression. In this paper, we leveraged the knowledge-based depression terminology to 
integrate data obtained from various structured and unstructured clinical and administrative 
data sources to build decision models that identified patients in need of advanced care for 
depression. 
 
5.2 Materials and Methods 
5.2.1 Patient group 
 We extracted a population of 84,317 adult patients (≥ 18 years of age) with one or 
more outpatient visits at Eskenazi Health, Indianapolis. Indiana, between the years 2011-
2016. 
 
5.2.2 Patient subset selection 
 We sought to predict the need for advanced care for depression across: (a) the 
overall patient population and (b) different groups of high-risk patients. We selected three 
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high-risk patient groups: Group A) patients with a prior diagnosis of depression, Group B) 
patients with a Charlson Comorbidity Index (Charlson et al., 2008) of >=1, and Group C) 
patients with a Charlson Comorbidity Index of >=2. Patients with a prior diagnosis of 
depression were identified as a high-risk group, as their illness may re-emerge or worsen 
based on other health conditions from which they may suffer. Patients with Charlson 
indexes >= 1 and >=2 were selected due to the high prevalence of depression across 
patients suffering from chronic illnesses, and its ability to worsen health outcome for 
patients. We also identified a fourth group (Group D), which comprised all unique patients 
identified in groups A-C. By identifying various patient groups, we hoped to: (a) capture 
as many of the overall number of patients in need of advanced care for depression and (b) 
compare which patient group was most suitable for use in screening for need of advanced 
care. Groups A-D were identified by scanning clinical data on each of the 84,317 patients 
(master patient list) to identify if they had a prior diagnosis of depression and calculate 
their individual Charlson Comorbidity Index.  
 
5.2.3 Preparation of gold standard 
 We defined patients in need of advanced care for depression as patients who had 
received a referral to a certified mental health provider for more specialized treatment for 
depression. We performed natural language processing of physician order notes to identify 
patients in the master patient list who had received such a referral/s. 
 
5.2.4 Data preparation 
 We obtained longitudinal health records on each patient from the Indiana Network 
for Patient Care (INPC), a statewide health information exchange server (McDonald et al., 
2005; Overhage, 2016). The dataset included a wide array of patient data, including patient 
demographics, diagnosis, and visit data reported in both structured and unstructured form. 
All clinical data was obtained in the form of structured ICD-9 and ICD-10 codes. We 
assessed extracted data against the depression terminology and used relationships 
presented within the UMLS Metathesaurus to identify concepts for inclusion as features. 
Due to the distributed nature of clinical data available, we decided to categorize ICD-9 and 
ICD-10 codes.  
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 We tabulated vectors for each patient group under study. In the event that the patient 
under study had received a referral for depression treatment, the data vector was only 
comprised of medical data recorded prior to the aforesaid referral. A master data vector 
encompassing all 84,317 patients was also created using the same approach. 
 
5.2.5 Decision model building 
 We split each of the five data vectors (four patient groups and one master data 
vector) into random groups of 90% training data and 10% test data. Each training data set 
was used to train a decision model using the Random Forest classification algorithm 
(Breiman, 2001). The Random Forest algorithm was selected due to its track record of 
successful use in decision modeling for healthcare challenges, as well as its ability to 
perform feature selection. We used Python programming language (V 2.7.6) for all data 
pre-processing tasks, and the Python scikit-learn package for decision model development 
and testing (Pedregosa et al., 2011). 
 
5.2.6 Analysis 
 Each decision model was evaluated using the 10% holdout test set. Results 
produced by each decision model were evaluated using Receiver Operating Characteristic 
(ROC) values, which measure classifier accuracy. Youden’s J Index (Youden, 1950) was 
used to identify optimal sensitivity and specificity for each decision model. 
 
 A flowchart representing our workflow from patient group election to decision 
model evaluation can be seen in figure 5.1.  
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Figure 5.1 A flowchart representing our workflow from patient group election to decision 
model evaluation 
 
5.3 Results 
 We identified a total of 12,432 patients with a diagnosis of depression (group A), 
32,249 patients with a Charlson Index of 1 or greater (group B), and 7,415 patients with a 
Charlson Index of 2 or more (group C). Overall, these three groups identified a total of 
37,560 unique patients (Group D).  
 
 The master patient list, as well as each of the four high-risk patient groups, 
represented an adult, urban population: predominantly female and with high disease 
burdens (table 5.1). The populations identified by their Charlson indexes were older (mean 
age >50 years) than the population identified with depression (46.31 mean age). 
Additionally, populations identified based on Charlson indexes were predominantly 
African-American. In contrast, the population identified by depression diagnosis were 
predominantly non-Hispanic whites. As anticipated, the prevalence of depression across a 
patient population with a Charlson Index of 1 or greater (30.18%) and a patient population 
with a Charlson Index of 2 or greater (37.25%) was greater than across the master patient 
list (19%). 
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Table 5.1. Characteristics of the master patient list/groups of high-risk patients used for 
decision model building 
Characteristic of interest Master 
patient set 
Group A  Group B Group C Group D 
Definition All 
patients 
Patients 
with a 
prior 
diagnosis 
of 
depression 
Patients 
with a 
Charlson 
Index of 
>= 1 
Patients 
with a 
Charlson 
Index of 
>= 2 
All 
unique 
patients in 
groups A-
C 
Patient group size  
(Patient group size as a 
% of the master patient 
list)  
N= 
84,317 
n=12,432 
(14.74%) 
n=32,249 
(38.25%) 
 
n=7,415 
(8.8%) 
 
n = 
37,560 
(44.5%) 
Need of advanced care 
for depression 
(Need of advanced care 
for depression as a % of 
patients in each group) 
n = 6992 
(8.29%) 
n = 3,683 
 (30.04%) 
 n = 4,016 
(12.94%) 
n = 1,026 
(21.6%) 
n = 5,612 
(80.26%) 
Demographics 
Age (mean, sd) 49.3  
(15.6) 
46.31 
(14.74) 
51.94 
(14.55) 
59.5 
(12.33) 
50.3 
(14.93) 
Male gender 35.1% 30.22% 39.8% 43.98% 42.03% 
Race/ethnicity 
White (non-Hispanic) 25.2% 44.62% 33.38% 37% 35% 
African-American (non-
Hispanic) 
37.2% 32% 42.78% 47.26% 40.12% 
Hispanic or Latino 19.5% 11.12% 10.6% 4.94% 7.38% 
Diagnoses 
Depression (%) 19% 100% 30.18% 37.25% 37.51% 
Charlson Index score 
(mean, sd) 
0.8  
(1.3) 
0.22  
(0.75) 
1.89  
(1.27) 
3.85  
(1.14) 
1.62  
(1.35) 
Hospitalizations (mean, sd) 
ED visits during current 
month (mean, sd) 
0.21 
(1.03) 
0.33  
(1.48) 
0.26  
(1.15) 
0.31  
(1.14) 
0.27  
(1.17) 
ED visits prior to 
previous months (mean, 
sd) 
3.73 
(14.40%) 
4.69 
(18.73) 
8.63  
(24.2) 
10.71 
(31.36) 
8.03  
(23.67) 
 
 Figure 5.2 presents a Venn diagram presenting overlap across the high-risk patient 
groups identified for the study. 
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Figure 5.2 Overlap between the patient subsets identified for the study 
 
 A total of 6,992 (8.29%) of the 84,317 patients in the master patient list were in 
need of advanced care for depression. Group A captured 3,683 (52.68%) of these patients. 
Group B captured 4016 (57.43%) and group C captured 1,026 (14.67%). Overall, all three 
patient groups were able to identify 5,612 (80.26%) of all patients in need of advanced care 
for depression. 
 
5.3.1 Feature selection using depression terminology 
 Previously, we developed a knowledge-based depression taxonomy using 
knowledge-based terminology extraction of the UMLS Metathesaurus. The taxonomy was 
developed by performing a literature search on Ovid Medline to identify publications that 
discuss depression and its treatment, and then using Metamap (Aronson & Lang, 2010), a 
Natural Language Processing (NLP)-based tool to map these abstracts against the UMLS 
Metathesaurus (U.S. National Library of Medicine, 2016), a large, multipurpose, multi-
lingual thesaurus that contains millions of biomedical and health-related concepts, 
synonymous names, and their relationships across 199 medical dictionaries (U.S. National 
Library of Medicine, 2015). The most frequently occurring UMLS concepts were compiled 
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into a terminology using the Web Ontology Language (OWL), a semantic web language 
that is widely used to represent ontologies. 
 
 Comparison of patient data against the aforementioned depression terminology 
resulted in the identification of 1,150 unique concepts for inclusion in each decision model. 
A detailed list of features included in each of the decision models is presented in Appendix 
9.4. 
 
5.3.2 Decision model performance 
 The decision model predicting need of advanced care across the master population 
reported a moderate ROC score of 78.87% (optimal sensitivity = 68.79%, optimal 
specificity = 76.30%). However, decision models to predict need of advanced care across 
patients’ groups A-D performed significantly better. Group A (patients with a prior 
diagnosis of depression) reported an ROC score of 87.29% (optimal sensitivity = 77.84%, 
optimal specificity = 82.66%). Group B (patients with a Charlson Index of >= 1) reported 
an ROC score of 91.78% (optimal sensitivity = 81.05%, optimal specificity = 89.21%). 
Group C (patients with a Charlson Index of >= 2) reported an ROC score of 94.43% 
(optimal sensitivity = 83.91%, optimal specificity = 92.18%), while Group D (list of unique 
patients from groups A-C) reported an ROC score of 86.31% (figure 5.3) (optimal 
sensitivity = 75.31%, optimal specificity = 76.03%). Precision-recall curves for each 
decision model are presented in Appendix 9.5.  
 
 The top 20 features for each decision model, as ranked using LASSO scores, can 
be seen in Appendix 9.6. Appendix 9.7 presents the co-occurrence of these top 20 features 
across each decision model under study. In assessing the top ranked feature selected by 
LASSO for each decision model, we found significant overlap among the top features for 
each of the high-risk patient populations. However, Essential (primary) hypertension, 
Depression, Gender, and Number of outpatient visits appears in the top 20 feature lists for 
every patient population under test. 
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Figure 5.3 ROC curves produced by decision models predicting need of advanced care 
across each patient group under study 
 
5.4 Discussion 
 The decision model to predict need of advanced care for depression across the entire 
patient population achieved an ROC score of 78.87%. In comparison, decision models that 
predicted need of advanced care across four high-risk patient populations performed better, 
with ROC scores ranging from 86.31%-94.43%. Additionally, optimal sensitivity and 
specificity for each decision model was significantly high, and demonstrated the models’ 
potential for practical implementation.  
 
 We attribute the comparatively low performance of the decision model developed 
using the master patient set to: (a) the unbalanced nature of the gold standard (Khalilia, 
Chakraborty, & Popescu, 2011) caused by the relatively low prevalence (8.29%) of patients 
in need of advanced care in comparison to the overall patient population and (b) the sparsity 
of clinical data available for some of the patients in the overall patient population, which 
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affected the robustness of features used in the decision model. The high performance of the 
decision models built using high-risk patient groups could be attributed to the balanced 
nature of the gold standard due to the higher prevalence of patients in need of advanced 
care for depression across each of the high-risk patient groups. While various publications 
have presented approaches to address data imbalance, we did not pursue such as approach, 
as we wished to focus on demonstrating methods that would be useful to potential 
implementers who could replicate our efforts across other datasets, which may or may not 
be imbalanced. 
 
 In assessing prediction performance, group C (patients with a Charlson Index >= 
2) yielded the highest AUC score (97.43%). Groups A (patients with a diagnosis of 
depression) and B (patients with a Charlson Index >= 1) reported lesser AUC scores. 
However, group C captured the least number of patients in need of advanced care in 
comparison to groups A and B. However, it is noteworthy that none of the decision models 
developed using high-risk populations could capture all patients in need of advanced care. 
Overall, all three models could capture only 80.26% of all patients in need of advanced 
care. The remainder (19.74%) of the patients in need of advanced care did not qualify for 
any of the three high-risk patient populations that we considered. We hypothesize that a 
share of the missing 19.74% patients should have fallen into one of the three high-risk 
patient groups, and thus been eligible for detection.  
 
 We present a novel application of machine learning to address a question of 
significant clinical relevance. We demonstrated the ability to predict need of advanced care 
for depression across high-risk patients using a host of clinical and behavioral determinants 
with considerable levels of accuracy. These efforts can be adapted to other challenges, such 
as improving referrals to wraparound mental health services (Winters & Metz, 2009). Since 
wraparound services are not delivered by primary care providers (Loeb, Binswanger, 
Candrian, & Bayliss, 2015), the ability to identify and refer patients in need of such services 
is extremely important (Jackson et al., 2013). Our efforts yield a highly accurate, automated 
approach for identifying patients in need of wraparound services for mental health, which 
is of growing importance to healthcare organizations and incentivized by changing 
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reimbursement policies. By predicting the need for advanced care across various high-risk 
populations, we offer potential implementers the option of selecting the best screening 
approach that meets their needs based on any practical limitations. Furthermore, our 
approach presents the ability to effectively identify the need for advanced care for 
depression without the risk of over-diagnosis and over-treatment, and without the use of 
existing screening mechanisms. 
 
 In the current study, we adopted a binary (present/absent) outcome flag for each 
feature used to train decision models. We hypothesize that switching to tabulated counts 
for each feature will increase the granularity of the feature vector, thereby increasing model 
performance. Additionally, our study did not consider temporality (time between outcome 
of interest and clinical condition). Inclusion of temporality measures within the model may 
further improve performance. Finally, our decision models were developed using patient-
based clinical, behavioral, and demographic data. Research presents significant evidence 
related to the role of various population-based socio-economic and environmental 
determinants in influencing the progression of mental health and depression (Allen et al., 
2014; Patel et al., 2010; Tanner, Martinez, & Harris, 2014; World Health Organization, 
2014). We hope to assess the value of including such population measures in improving 
decision model performance. 
 
 We also identified several limitations in our study approach. The patient group used 
in our study was obtained from the Eskenazi Health system, a safety-net population with 
significant health burdens. Thus, our models may not generalize to other commercially 
insured or broader populations. Our clinical and behavioral data was limited to diagnosis 
data extracted in the form of ICD codes. Using a wider range of clinical data on medical 
procedures, etc., may further improve decision model performance. None of the three 
patient groups captured all of the patients in need of advanced care for depression. The 
closest, group B (patients with a Charlson Index >=1), captured only 78.94% of all patients 
in need of care. We hypothesize that some patients in need of advanced care for depression 
were not included in any of the three models, as some of these patients may have missed 
data elements that would have categorized them as such. Additional efforts to identify 
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different groupings that lead to inclusion of more patients in need of advanced care may be 
warranted. Our approaches to identifying the most relevant features for model selection 
resulted in the top ranked features listed in Appendices F and G. However, we note that in 
the event of highly-correlated variables, the LASSO feature selection tends to select one 
feature over another, arbitrarily ignoring the second feature (Fonti & Belitser, 2017). This 
may have resulted in the exclusion of some features that were as relevant, but highly 
correlated with other features. 
 
 Finally, studies present that social determinants of health, such as low-educational 
attainment, poverty, unemployment, and social isolation, may have a significant impact on 
depression and the need for treatment (Fryers, Melzer, Jenkins, & Brugha, 2005; World 
Health Organization, 2014). We propose to expand our models using social determinants 
of health to assess their impact on decision model performance.  
 
 In conclusion, these results show considerable potential for enabling preventative 
care and can be easily adopted to existing clinical workflows to improve access to 
wraparound healthcare services. 
 
5.5 Conclusion 
 Our efforts demonstrate the ability to identify patients in need of advanced care for 
depression across: (a) an overall patient population and (b) various groups of high-risk 
patients using a wide range of structured and unstructured data that represent a patient’s 
clinical and behavioral determinants. While all models yielded significant performance 
accuracy, models focused on high-risk patient populations yielded comparatively better 
results. Furthermore, our methods present a replicable approach for implementers to follow 
based on their own needs and priorities. However, decision model performance may differ 
based on the availability of patient data at each healthcare system. These results show 
considerable potential for enabling preventative care and can be easily adopted to existing 
clinical workflows to improve access to wraparound healthcare services. 
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6 AIM 3: THE IMPACT OF PATIENT- AND AGGREGATE-LEVEL SOCIAL 
DETERMINANTS OF HEALTH IN PREDICTING NEED OF ADVANCED 
CARE FOR DEPRESSION 
6.1 Introduction 
 Social determinants of health (SDH) are defined as “the structural determinants and 
conditions in which people are born, grow, live, work and age” (Marmot et al., 2008). They 
include factors such as an individual’s socio-economic status, education, neighborhood, 
and physical environment; employment, education, and access to various services 
(Braveman et al., 2011; Marmot, Allen, Bell, Bloomer, & Goldblatt, 2012; World Health 
Organization, 2010). SDH plays a significant role in susceptibility (Skinner, 2011), 
progression, and outcome of disease and illness (Cullen, Cummins, & Fuchs, 2012; Di 
Monte, 2003; Yu, Lin, & Lin-Tan, 2004). Research indicates that SDH influences the 
likelihood of smoking and shorter life expectancy (Marmot et al., 2008) and may have 
multi-generational impacts (Chetty, Hendren, Kline, & Saez, 2014). 
 
 There have been significant limitations in the use of social determinants of health 
(SDH) for improving healthcare delivery. Historically, SDH was collected for use by 
public health, environmental, and social services, and curated at aggregate geographical 
levels (Comer, Grannis, Dixon, Bodenhamer, & Wiehe, 2011). Challenges in collecting, 
managing, and using such data, as well as integrating them with clinical sources, has 
prevented the use of SDH in informing healthcare delivery. However, these barriers are 
coming down. Rising interest in the field of precision medicine has highlighted the role of 
social determinants on an individual’s health (Martin Sanchez, Gray, Bellazzi, & Lopez-
Campos, 2014) and has led to increasing support for capturing such data in clinical 
information systems using standard clinical terminology (LaBrec, 2016). Increasing 
support for interoperability and Health Information Exchanges (HIE) (Vest & Gamm, 
2010) are enabling better integration of SDH captured outside the health information eco-
system. 
 
 The predictive modeling domain poses significant potential for leveraging SDH 
data in support of organizational planning, research, and healthcare policy activities (Bates, 
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Saria, Ohno-Machado, Shah, & Escobar, 2014; Kansagara et al., 2011; Schneeweiss, 
2014). To date, there has been limited efforts to capitalize on SDH for predictive modeling. 
However, studies that do leverage SDH for predictive modeling are restricted to a 
minimum number of social determinants that do not present a complete picture of an 
individual’s environment (Torres et al., 2015). Additionally, SDH may not be equally 
relevant or as impactful across all healthcare challenges. Thus, attempts to demonstrate the 
value of SDH in improving healthcare delivery must focus on healthcare challenges that 
are strongly influenced by SDH. 
 
 We sought to determine the value of SDH in predictive modeling activities for the 
treatment of depression, the most common type of mental illness the world over (Ferrari et 
al., 2013). Depression affects over 26% of the U.S. adult population (Kessler et al., 2005). 
It is a leading cause of disability for Americans age 15-44 years and is responsible for 
almost 400 million disability days per year (Mathers, 2008). The incremental economic 
burden of depression (covering medical, pharmaceutical, workplace, and suicide-related 
costs) in the U.S. was evaluated at $210.5 billion in 2010, a 21.5% increase from 2005 
(Greenberg et al., 2015). The onset, progression, and outcome of depression is significantly 
impacted by an individual’s socio-economic environment (Saveanu & Nemeroff, 2012; 
Wong, Dong, Andreev, Arcos-Burgos, & Licinio, 2012), making it an ideal use case to 
evaluate the value of SDH in healthcare decision making. 
 
 In aim 2, we leveraged a host of clinical and behavioral data extracted from a 
statewide HIE to build decision models that predicted need of advanced care for 
depression. While these models yielded significantly high performance, they were an 
infeasible solution for healthcare facilities without access to a high volume of clinical data 
that could only be obtained from a robust HIE. In comparison, SDH data that describe the 
overall health of an individual and community may be easily available and could be used 
to augment the accuracy of such decision models. Additionally, models that leverage SDH 
may be easily interpretable, and thus, be of additional value to the healthcare community. 
In this paper, we evaluate the ability to: (a) implement conceptual SDH frameworks with 
patient- and population-centric data for use in decision-model building, (b) leverage SDH 
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data to improve performance of decision models that predict need for advanced care for 
depression, and (c) identify the minimal number of clinical, behavioral, and SDH features 
required to build actionable decision models.  
 
6.2 Materials and methods 
6.2.1 Patient subset selection 
 This study leveraged the same patient sets that were prepared for aim 2. We 
identified a population of 84,317 adults (≥ 18 years) with >=1 outpatient visit at Eskenazi 
Health of Indianapolis, Indiana, between the years 2011-2016. Eskenazi Health serves as 
the public safety-net health system of Marion County, Indiana.  
 
 From this master patient population, we identified three patient subsets representing 
high-risk patient populations: Group A) patients with a prior diagnosis of depression, 
Group B) patients with a Charlson Comorbidity Index (Charlson et al., 2008) of >=1, and 
Group C) patients with a Charlson Comorbidity Index of >=2. Patients with a prior 
diagnosis of depression were identified as being at high-risk for need of advanced care for 
depression given that their illness may re-emerge or worsen based on other health 
conditions from which they may suffer. Patients with Charlson indexes >= 1 and >=2 were 
selected due to the high prevalence of depression across patients suffering from chronic 
illnesses, and its ability to worsen health outcomes for patients. Groups A-C were identified 
by scanning clinical data on each of the original 84,317 patients to identify if they had a 
prior diagnosis of depression and calculate their individual Charlson Comorbidity Index. 
  
6.2.2 Preparation of clinical and behavioral datasets 
 Longitudinal health records on each patient were extracted from the Indiana 
Network for Patient Care (INPC), a statewide health information exchange server 
(McDonald et al., 2005; Overhage, 2016). The dataset included a wide array of patient data, 
including patient demographics, diagnosis, and visit data.  
 
 We assessed extracted data against the depression terminology and used 
relationships presented within the UMLS Metathesaurus to identify concepts for inclusion 
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as features. Due to the distributed nature of clinical data available, we decided to categorize 
ICD-9 and ICD-10 codes.  
 
 We developed data vectors for each of the three high-risk patient groups under 
study. In the event that the patient under study had received a referral for depression 
treatment, the data vector was only comprised of medical data recorded prior to the 
aforesaid referral. A master data vector encompassing all 84,317 patients was also created 
using the same approach. These datasets would hereafter be referred to as clinical data 
vectors.  
 
6.2.3 Preparing social determinants of health 
 We leveraged the Kaiser Family Foundation (KFF) social determinants framework 
(Heiman & Artiga, 2015) to identify and categorize SDH’s of interest. The KFF framework 
categorizes social determinants into: (a) economic stability, (b) neighborhood and physical 
environment, (c) education, (d) food, (e) community and social context, and (f) healthcare 
system-based factors. 
 
 SDH data were obtained from two sources: (a) patient-centric data extracted from 
codified INPC data based on a list of ICD-10 codes representing SDH (LaBrec, 2016) that 
were mapped to ICD-9 using General Equivalence Mappings (GEM) (Butler, 2007) 
(Appendix 9.8) and (b) public health and environmental data obtained from the Polis 
Center, a reputed research organization that seeks to understand the communities that 
people live in; developers of SAVI, the nation’s largest community information system; 
and the Indiana State Department of Health. We obtained a total of 14 SDH from the INPC 
and 48 features from the Polis data (Appendix 9.9). The Polis data were aggregated across 
224 census tracts and 20 HPA. Data obtained from the Polis Center was linked to patients 
via the census tract identified from each patient’s address. For machine-learning purposes, 
we reduced the high variability of the SDH data by classifying each feature into smaller 
bins determined by Sturges’ rule (Scott, 2009). 
 
6.2.4 Preparation of gold standard 
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 Patients in need of advanced care for depression were defined as those individuals 
who had received a referral to a certified mental health provider for more specialized 
treatment for depression. We performed natural language processing of physician order 
notes to identify patients in the master patient list who had received such a referral/s. 
 
6.2.5 Decision model building 
 In aim 2, we found that the need for advanced care for each of the groups under 
testing could be predicted with significantly high accuracy using significant quantities of 
non-SDH data, alone. However, as discussed previously, not all healthcare facilities are 
able to produce the volume of clinical and behavioral data used in our previous efforts. We 
sought to assess the minimal number of features necessary to build accurate models and 
assessed whether the use of socio-economic data would significantly improve 
performance.  
 
 We identified the most valuable patient-centric features across each of the four data 
vectors under testing using the Least Absolute Shrinkage and Selection Operator (LASSO) 
(Tibshirani, 1996). Using this approach, we produced ranked feature lists. 
 
 Next, for each dataset, we used the ranked feature lists to build multiple decision 
models starting from a decision model that included the five top ranking features, 
iteratively adding on the next important feature until each model was comprised of the 50 
top ranking features. The performance of each decision model developed using the top n 
ranking clinical and behavioral features were evaluated against a decision model that 
incorporated the top n clinical features and all SDH features. As an example, for patient 
group A, we began by building a decision model consisting of five patient-centric features. 
The performance of this model was compared to a decision model built using the same five 
features plus 50 socio-economic features. Next, we added the next most important patient-
centric feature and built a decision model consisting of these six features. This model was 
compared to a decision model built using the same six features plus 50 socio-economic 
features. We continued building models until we had included the top 50 most relevant 
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patient-centric features. Thus, for patient group A, we built a total of 90 ([50-5]*2) decision 
models.  
 
 Each training dataset was used to build a decision model using the random forest 
classification algorithm. We selected random forest (Breiman, 2001) for decision-model 
building due to its proven track record of use in decision modeling for healthcare 
challenges.  
 
 
Figure 6.1 Workflow depicting the study approach, from data collection to decision-model 
building 
 
 All data cleaning, decision-model development, and testing was performed using 
python and scikit-learn software (Pedregosa et al., 2011). 
 
6.2.6 Analysis 
 Each decision model was trained and tested using 10-fold cross validation (Zhang, 
1993). For each decision model, we calculated accuracy in the form of F1-scores, together 
with 95% confidence intervals.  
 
6.3 Results 
 The master patient list, comprised of 84,317 patients, represented a predominantly 
female adult population with high disease burdens (table 5.1). The patient population was 
distributed across 37 zip codes and 224 census tracts. Group A (prior diagnosis of 
depression) comprised 12,432 patients. Group B (Charlson Index of 1 or greater) 
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comprised 32,249 patients, while group C (Charlson Index of 2 or greater) comprised 7,415 
patients. Overall, each of the patient subgroups under test was also evenly distributed 
geographically (Appendix 9.10). In evaluating the data obtained from the INPC, we found 
that a considerable number of patients had social data recorded in the form of ICD-9 and 
ICD-10 codes 9 (Appendix 9.8). 
 
6.3.1 Decision model performance 
 The performance of decision models for each patient population under test are 
presented in the form of F1 scores and 95% confidence intervals against the feature set size 
used. (figures 6.2 to 6.5). 
 
 
Figure 6.2. Group A: F1-scores and 95% confidence intervals reported by feature set size 
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Figure 6.3. Group B: F1-scores and 95% confidence intervals reported by feature set size 
 
 
Figure 6.4. Group C: F1-scores and 95% confidence intervals reported by feature set size 
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Figure 6.5. Master patient population: F1-scores and 95% confidence intervals reported by 
feature set size 
 
 For group A, F-1 scores for decision models developed using clinical features 
selected in ascending order of importance started with 73.83% for decision models using 
just one feature, and rose to ~84% in models using top ~10 clinical features, at which point 
they remained constant. Models augmented with SDH features followed a similar pattern, 
with f1 scores starting at 70.73% for decision models with just one clinical feature, rising 
to ~85%, and then remaining constant as further features were increased. There was no 
statistically significant change in model performance at ~83% f1- score. 
 
 For group B, F-1 scores for decision models developed using clinical features 
selected in ascending order of importance, starting with 88.40% for decision models using 
just one feature, rising to ~92% in models using top ~20 clinical features, at which point 
they remained constant. Models augmented with SDH features followed a similar pattern, 
with f1-scores starting at 87.16% for decision models with just one clinical feature, rising 
to ~92% in models using the top ~15 features, and then remaining constant as further 
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features were increased. There was no statistically significant change between models 
using clinical or SDH data. 
 
 For group C, F-1 scores for decision models developed using clinical features 
selected in ascending order of importance started with 86.30% for decision models using 
five features, rose to ~84% in models using top ~15 clinical features, at which point they 
remained constant. Models augmented with SDH features followed a similar pattern, with 
f1-scores starting at 85.70% for decision models with just five clinical features, rising to 
~92% in models using the top ~15 features, and then remaining constant as further features 
were increased. There was no statistically significant change between models using clinical 
or SDH data. 
 
 For the master patient population, F-1 scores for decision models developed using 
clinical features selected in ascending order of importance started from x% for decision 
models using five features, rose to ~92% in models using the top ~11 clinical features, at 
which point they remained constant. Models augmented with SDH features reported f1-
scores starting at y% for decision models with just five clinical features, and peaking at 
~84% in models using the top ~11 features. At this point, F-1 scores fell back to ~82%, 
and remained constant as further features were increased. However, there was no 
statistically significant change between models using clinical or SDH data. 
 
 The top 20 features for each decision model, as ranked using LASSO scores, can 
be seen in Appendix 9.6. Appendix 9.7 presents the co-occurrence of these top 20 features 
across each decision model under study.  
 
6.4 Discussion 
 This study indicates the ability to predict the need for advanced care for depression 
across: (a) different groups of high-risk patients and (b) the overall patient population with 
significant accuracy using only a minimal number of clinical, behavioral, and social 
determinants of health. By building decision models using varying numbers of clinical and 
behavioral features ranked by descending order of importance, we found that decision 
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model performance did not improve after the inclusion of the first ~15 top-ranked clinical 
features (Appendix 9.6). The inclusion of SDH into decision models built using clinical 
and behavioral data did not lead to any statistically significant performance improvements.  
 
 We hypothesize that the inclusion of patient and aggregate-level SDH did not lead 
to performance improvements due to several limitations: (a) weaknesses in our study 
population, which represented a high-risk population with high disease burdens spread 
across a relatively constrained safety net geography. A larger, more socially diverse patient 
population may represent greater variance, and thus, lead to greater improvements in 
decision model performance. (b) Aggregate socio-economic features were assigned based 
only on an individual’s current address. We did not consider changes in an individual’s 
residence over time, nor changing exposures to different socio-economic environments 
caused by an individual’s occupation and/or movement during their day-to-day life. The 
aggregate SDH indicators used in this study may be improved by obtaining SDH data 
aggregated at a finer level of granularity than census tract and HPA level. Our results may 
also benefit from the inclusion of additional data sources, such as those available via Zillow 
(programmableweb.com, 2017), which may capture more up-to-date data elements; (c) a 
significant part of the clinical data used in our study was collected via ICD-9 codes, which 
did not support a wide range of socio-economic data. A more up-to-date clinical dataset 
captured using only ICD-10 codes may incorporate more patient-centric socio-economic 
data, and thus lead to improvements in decision-model performance.  
 
 Our study leveraged only a subset of potential clinical, behavioral, and SDH 
features. Other patient level features may be extracted from sources, such as wearable 
devices and activity trackers (Almalki, Gray, & Sanchez, 2015; Evenson, Goto, & Furberg, 
2015). Finally, our decision models did not consider data temporality/sequence of each 
event in performing prediction. Adopting a sequence-based deep learning algorithm, such 
as Long Short-Term Memory (LTSM) networks (Lipton, Kale, Elkan, & Wetzel, 2015) 
that identified patterns in sequential data, may improve decision-model performance.  
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 Our efforts present a comprehensive effort to implement a conceptual SDH 
framework by extracting SDH from patient-centric and aggregate-data sources captured 
within and outside the healthcare domain and leverage them for machine learning purposes. 
While the use of SDH indicators did not result in improvements in this specific scenario, 
our approach may be replicated across other populations and different socio-economic 
features, where the use of SDH may yield significant improvements. Our methods included 
implementation of the conceptual KFF framework on SDH. However, our methods may 
also be applied to other conceptual SDH frameworks, such as the Danaher framework 
(Danaher, 2011), the Rural Community Health & Well-Being Framework (Annis, Racher, 
& Beattie, 2004), the World Health Organization’s conceptual framework for action on 
SDH (Solar & Irwin, 2010), and the Area-based deprivation indices (ABDI) (Schuurman, 
Bell, Dunn, & Oliver, 2007), which may be more suitable for other healthcare challenges 
based on location and data available for use. Additionally, there is a need for more 
comprehensive research on how existing SDH frameworks can be leveraged to capture the 
element of temporality, covering changes in an individual’s: (a) residence over time, (b) 
day-to-day movement across different geographies, and (c) occupational exposures, thus 
making them more suitable for use in machine-learning tasks. 
 
6.5 Conclusion 
 It is possible to integrate patient and aggregate-level SDH with patient-level clinical 
and behavioral data for effective decision-model building for predicting the need for 
advanced care for depression. Our efforts constitute a comprehensive plan to implement a 
conceptual SDH framework by extracting SDH from patient-centric and aggregate data 
sources captured within and outside the healthcare domain, and leveraging them for 
machine-learning purposes. Decision models built using the aforementioned data yielded 
significantly high performance measures using only a relatively small number (~15) of 
most relevant features. The use of SDH did not lead to any statistically significant 
performance improvements in any of the decision models under test. However, our 
methods can be applied to a multitude of other healthcare questions, where the inclusion 
of SDH may yield improved results. There is an urgent need for research and 
implementation efforts around capturing and sharing patient- and population-centric SDH, 
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as well as better approaches to include the element of temporality in modelling SDH for 
machine-learning purposes. 
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7 DISCUSSION 
 We sought to investigate alternative approaches to improve the detection of patients 
in need of advanced care for depression by leveraging existing knowledge, information 
sources, clinical workflows, and data analytics. Our efforts were be broken into three 
incremental aims. 
 
 In aim 1, we developed a comprehensive depression terminology that covered a 
wide range of clinical, behavioral, and SDH that influenced the need for advanced care for 
depression. The depression terminology was developed by performing an extensive 
literature search for publications that discuss depression and its treatment, using Metamap 
to extract UMLS concepts associated with the most frequently recurring conditions from 
the UMLS Metathesaurus. The depression terminology comprised 7,402 concepts 
representing patient-level clinical, behavioral, and social determinants of health that were 
mapped to 45,297 UMLS concepts from across 70 different terminologies, as well as 64 
additional concepts representing aggregate-level social determinants of health. Together, 
these concepts represented a wide range of features that influenced the onset, progression, 
and outcome of depression. 
 
 In aim 2, we leveraged the depression terminology to extract comprehensive 
longitudinal patient data from the INPC, a large, statewide HIE. By analyzing a population 
of 84,317 patients, we identified several high-risk populations for predicting need of 
advanced care for depression: (a) patients with a prior diagnosis of depression (n=12,432), 
(b) patients with a Charlson Index >= 1 (n=), and (c) patients with a Charlson Index of >=2 
(n=7,415), as well as the overall patient population (n=84,317). We leveraged the 
depression terminology developed in aim 1 to extract a wide range of clinical data covering  
both chronic and acute conditions, as well as behavioral data. We. built a series of decision 
models that predicted need of advanced treatment for depression using these features. 
 
 In aim 3, we assessed the potential to improve the performance of decision models 
built in aim 2 by integrating a host of patient- and aggregate-level SDH into existing 
datasets. However, since the models developed in aim 2 had already achieved significantly 
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high levels of performance, we assessed the contribution of SDH by building incremental 
decision models consisting of the top n clinical and behavioral features and comparing their 
performance against models built using the same number of features plus SDH. We found 
that: (a) performance of decision models plateaued after ~15 clinical features, and (b) 
inclusion of patient and aggregate-level SDH did not lead to statistically significant 
performance improvement in any of the models. 
 
 Overall, our efforts contribute to best practices on the use of data-driven decision 
making and existing medical knowledge to inform actionable, cost-efficient approaches to 
influence access to healthcare delivery. Through the use of existing medical knowledge, as 
derived from the depression terminology for decision-model building, we seek to close the 
gap on the chasm between healthcare and machine-learning domains, thereby leading to an 
approach that is acceptable to all stakeholders. Our efforts are timely given: (a) increasing 
interest in big data and precision medicine, which has led to the availability of a glut of 
data sources of varied value to healthcare (Gligorijević, Malod-Dognin, & Pržulj, 2016; 
Kasthurirathne, Biondich, Mamlin, Cullen, & Grannis, 2017) and (b) falling costs of 
computational storage, memory, and processing bandwidth (McAfee, Brynjolfsson, 
Davenport, Patil, & Barton, 2012), as well as a rapidly evolving machine learning domain 
(Schmidhuber, 2015) that has led to a multitude of neural network and deep learning-based 
solutions that seek to address healthcare challenges (Liang, Zhang, Huang, & Hu, 2014; 
Miotto, Wang, Wang, Jiang, & Dudley, 2017).  
 
 In terms of big data and precision medicine, our findings help inform the 
identification of the most pertinent data sources based on accessibility, completeness, and 
value to precision medicine. However, much of these improvements come at the cost of 
clarity and simplicity; neural networks are exceedingly complex and difficult to interpret 
(Bengio, Courville, & Vincent, 2013; Schmidhuber, 2015), which drives a wedge between 
rich sources of medical data and healthcare workers who stand to benefit from them. In 
contrast, our machine-learning efforts prioritized interpretability and simplicity of decision 
models. These qualities promise healthcare practitioners a more acceptable path to benefit 
from these technological advances. The use of existing knowledge in the form of published 
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research also addresses the research-to-implementation gap (Brownson, Colditz, & 
Proctor, 2017), enabling stakeholders to benefit from breakthroughs in research at a faster 
pace. 
 
 Our focus on informing referrals to supplementary/wraparound services are in line 
with changing reimbursement policies that incentivize preventive health care (Casalino et 
al., 2003; McGinnis & Foege, 1993). Additionally, our approaches demonstrate the value 
of comprehensive data collection and sharing for medical decision making, from patient 
referrals and previous visit history to aggregate-level SDH. The use of non-traditional 
administrative data, as well as public health/socio-economic data demonstrates, diverge 
from the usual confines of the “clinical” domain and build a platform for collaboration 
among a wider range of stakeholders. 
 
 In aims 2 and 3, we attempted to predict the need for advanced care for depression 
across: (a) various subsets of high-risk patient populations and (b) the overall patient 
population. In each case, we found that decision models assessing high-risk patient subsets 
yielded better results than models built using the overall patient population. We 
hypothesize that the overall patient population failed to achieve better performance due to: 
(a) missing clinical observations leading to sparse data vectors, which may decrease 
machine-learning performance and (b) a relatively low prevalence of need for advanced 
care for depression across the overall population, leading to an imbalanced gold standard 
for machine learning (Prati, Batista, & Monard, 2009). 
 
 Our approach developed decision models for a number of high-risk populations. 
These populations represent easily identifiable groups based on a subset of easily 
discernable clinical conditions and disease burdens. However, it is unclear whether these 
populations are the most clinically relevant given the data at hand. Thus, we recommend 
further research using machine learning approaches, specifically clustering approaches, 
such as K-means (Hartigan & Wong, 1979) or SOM (Kohonen, 1982), to identify more 
suitable patient populations based on the data under study. Predicting the need for advanced 
care using decision models for other, more clinically relevant populations, may yield better 
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model performance using a smaller subset of features. Groupings of the most important 
features, as presented in Appendices H and G, also suggest the possibility of developing 
more clinically relevant patient subsets. 
 
 As discussed previously, we selected the Random Forest algorithm for decision-
model building based on the need to develop high performance models that were easily 
interpretable to our clinical audience (Qi, 2012). Other, more advanced decision-modeling 
approaches, such as neural networks (Haykin & Network, 2004), have shown potential to 
improve marching learning performance across other healthcare-related challenges. 
However, neural networks are more cost intensive and yield results that are not easily 
interpretable (Bengio et al., 2013). Additionally, it is unclear if they can contribute to our 
study, given the significant levels of accuracy already achieved using Random Forest 
models. We recommend that neural networks be considered in a scenario where 
sequence/temporality of clinical events are being evaluated or where performance of 
Random Forest models are unsatisfactory. 
 
 In aim 3, we found that the inclusion of patient and aggregate-level SDH did not 
lead to improvements in decision model performance. However, the informatics 
community should not conclude that there is no value in including SDH for improving 
healthcare decision making based on these results. We believe that SDH will continue to 
play an integral role in influencing healthcare, as the collection and use of patient and 
aggregate-level SDH increases. We applaud the Institute of Medicine (IOM)’s decision to 
recommend that SDH be captured in Electronic Health Records (Institute of Medicine. 
Committee on the Recommended Social Behavioral Domains Measures for Electronic 
Health Records, 2014), as well as the International Classification of Disease (ICD) for 
enabling SDH collection by introducing additional SDH codes to ICD-10 (LaBrec, 2016). 
The Logical Observation Identifiers Names and Codes (LOINC) terminology is also 
engaged in incorporating SDH codes. however, we did not consider LOINC codes due to 
limited availability in the INPC dataset. We anticipate that the availability of patient-level 
SDH will improve as the adoption of these codes increase. Additionally, other patient-level 
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SDH related to an individual’s family/social support may be inferred from their family 
medical history. 
 
 At the present time, the scarcity of SDH data availability across the U.S. presents a 
significant barrier for the implementation of our efforts outside the current settings. Despite 
recent interest in the use of social determinants for health (Alley, Asomugha, Conway, & 
Sanghavi, 2016; Solar & Irwin, 2010), there has been little groundwork done in the efficient 
collection of SDH at scale. The availability of aggregate SDH data may vary across 
regions. Additionally, the fragmented nature of SDH collection and lack of proper 
standardization of such data would also prevent its effective use in other large-scale 
systems. A potential alternative may be to rely on SDH elements captured by entities 
outside of the healthcare domain. For example, the online real estate marketplace, Zillow, 
presents a public API where certain social determinants covering the entire U.S. may be 
obtained (programmableweb.com, 2017). Other SDH on crime, environment, and 
education may be obtained from other commercial and non-commercial entities, albeit at 
different aggregate-levels. Additionally, there is a strong need for standards that support 
the collection and sharing of aggregate-level SDH. Despite of our inability to demonstrate 
value in leveraging SDH for predictive modeling, these efforts, together with previous 
initiatives (Kasthurirathne, Vest, et al., 2017), contribute to the meager body of existing 
knowledge on the use of SDH for healthcare decision making. As suggested previously, 
there is significant need for continued research that provides best practice guidelines on the 
use of SDH for use in machine learning for healthcare.  
 
 We identified a number of limitations that impact the internal and external validity 
of our efforts. In current clinical practice, healthcare teams that encounter patients with 
extremely serious cases of depression, which may lead to suicide or harmful behavior, 
generally take immediate action, directing these patients to the emergency department or 
elsewhere. This means that there will be no referral data on high-risk situations available 
to train the decision models—only data on situations that were considered non-life 
threatening. We do not anticipate this to be a problem, because patients with serious health 
needs would be easily detectable; thus, there is no need for an automated approach to 
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identify such patients. The lack of data on serious cases of depression, where urgent care 
is needed, limits our ability to develop conventional risk scores that would be more 
effective for implementation purposes. As alternate approach for developing risk scores 
based on this scenario would be to assess the level of risk based on prediction scores and 
use these as a measure to identify urgency of treatment desired. A similar approach was 
implemented via our efforts to predict the need for various wraparound health services to 
patients presenting at Eskenazi Health, Indianapolis, Indiana (Kasthurirathne, Vest, et al., 
2017). 
 
 Our work is limited by the accuracy and availability of aggregate socioeconomic, 
community, and public health data for Marion County, Indiana. For our current effort, SDH 
data was unavailable for patients who do not reside within Marion County. The accuracy 
of our models are also dependent upon the accuracy and completeness of clinical and 
behavioral data, as obtained from IHIE. We assume that many of the patients presenting at 
Eskenazi are return patients, and that IHIE is able to produce reasonable quantities of 
clinical and behavioral data from their health records. However, in the case of out-of-state 
patients or first-timers, there is very little or no clinical data at hand to provide appropriate 
judgment. In the case of out-of-state patients, SDH data would also be unavailable. The 
proper action for such a scenario is still unclear and depends on the performance of decision 
models built using only aggregate data. If such models perform adequately well, we may 
consider using them to predict outcomes for patients with no clinical data. However, this 
remains to be seen, based on the work to be performed. 
 
 Our aim is to identify patients in need of advanced treatment for depression. But 
how will we isolate these individuals from cases of historical need? Given that Eskenazi 
can only provide us with clinical data from 2010 forward, we anticipate that a significant 
majority of the data will indicate current and ongoing need for depression care. However, 
we are unable to facilitate other scenarios involving past need for depression care and 
acknowledge it as a limitation in our study. 
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 We acknowledge numerous studies that indicate an association between depression 
and an individual’s genetics (Cohen-Woods, Craig, & McGuffin, 2013; Flint & Kendler, 
2014; Hettema, 2010; Schwartz & Petersen, 2016). Unfortunately, IHIE does not currently 
support or persist with any genomic data. Furthermore, while cases of depression among 
immediate family members may indicate predisposition, existing IHIE data does not 
adequately support the ability to identify patient relationships without considerable effort 
involving Natural Language Processing (NLP)-based efforts. Additionally, the cost of 
genetic testing and processing has posed a significant barrier to enabling the widespread 
availability of such data for study. Thus, our study did not leverage any genetic data for 
analysis.  
 
 Finally, the decision whether to treat patients or to refer them to mental health lies 
with the provider. In some cases, providers may disagree on what constitutes an advanced 
care need and what they can treat on their own. Thus, our gold standard of referrals used 
in our analysis may be influenced by differences in providers’ personal preferences.  
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8 CONCLUSIONS 
 We leveraged a host of clinical, behavioral, and patient and population-centric 
social determinants of health informed by the fundamentals of precision medicine and a 
conceptual framework of social determinants of health to develop decision models capable 
of identifying patients in need of advanced care for depression. Models predicting need of 
advanced care across various high-risk populations and the overall patient population 
yielded significantly high results suitable for implementation at clinical settings. 
Additionally, we were able to achieve high performance with decision models that used a 
relatively small feature set. However, the use of SDH did not yield statistically significant 
performance improvements in any of the decision models that were tested. Irrespective of 
these results, our methods can be applied to a multitude of other healthcare questions, 
where the inclusion of SDH may yield improved results. Our research presents significant 
potential to automate the identification of patients in need of mental health services using 
machine learning techniques and relatively low human intervention/expertise. However, 
there is an urgent need for research and implementation efforts around capturing and 
sharing patient and population-centric SDH, as well as better approaches to including the 
element of temporality in modeling SDH for machine-learning purposes. 
 
  
 68 
9 APPENDICES 
9.1 Breakdown of Concepts of the depression terminology across each UMLS 
mandated semantic type and semantic group. 
Activities and behaviors 389 
 Activity 113 
 Behavior 7 
 Daily or recreational activity 29 
 Event 8 
 Governmental or regulatory activity 19 
 Individual behavior 71 
 Machine activity 8 
 Occupational activity 52 
 Social behavior 82 
Anatomy 204 
 Anatomical structure 5 
 Body location or region 33 
 Body part, organ, organ component 113 
 Body substance 20 
 Body system 16 
 Embryonic structure 1 
 Tissue 16 
Chemicals and drugs 604 
 Amino acid peptide or protein 152 
 Antibiotic 14 
 Biologically active substance 14 
 Biomedical or dental material 14 
 Chemical 2 
 Chemical viewed functionally 6 
 Chemical viewed structurally 5 
 Chemical drug 2 
 Element, ion or isotope 32 
 Enzyme 7 
 Hazardous or poisonous substance 24 
 Immunologic factor 20 
 Indicator reagent or diagnostic aid 7 
 Inorganic chemical 14 
 Nucleic acid nucleoside or nucleotide 6 
 Organic chemical 148 
 Pharmacological substance 137 
Concepts and ideas 2499 
 Classification 37 
 Conceptual entity 112 
 Functional concept 421 
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 Group attribute 15 
 Idea or concept 299 
 Intellectual product 15 
 Qualitative concept 604 
 Quantitative concept 492 
 Regulation or law 15 
 Spatial concept 210 
 Temporal concept 279 
Disorders 1250 
 Acquired abnormality 10 
 Anatomical abnormality 7 
 Cell or molecular dysfunction 2 
 Disease or syndrome 278 
 Experimental model or disease 2 
 Finding 492 
 Injury or poisoning 78 
 Mental or behavioral dysfunction 144 
 Neoplastic process 48 
 Pathologic function 83 
 Sign or symptom 106 
Genes and molecular sequences 194 
 Gene or genome 185 
 Nucleotide sequences 9 
Geographic areas 162 
 Geographic area 162 
Living beings 415 
 Age group 24 
 Family group  26 
 Group 11 
 Human 11 
 Patient or disabled group 26 
 Population group 143 
 Professional or occupational group 174 
Objects 213 
 Entity 2 
 Food 23 
 Manufactured object 166 
 Substance 22 
Occupations 108 
 Biomedical occupation or discipline 84 
 Occupation or discipline 24 
Organizations 171 
 Healthcare-related organization 132 
 Organization 29 
 Professional society 5 
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 Self-help or relief organization 5 
Phenomena 146 
 Biologic function 10 
 Environmental effect of humans  3 
 Human caused phenomenon or process 12 
 Laboratory or test results 30 
 Natural phenomenon or process 41 
 Phenomenon or process 50 
Procedures 1047 
 Diagnostic procedure 106 
 Educational activity 32 
 Healthcare activity 277 
 Laboratory procedure 95 
 Molecular biology research technique 1 
 Research activity 149 
 Therapeutic or preventive procedure 387 
 
9.2 Distribution of linkages between concepts of the depression terminology to other 
concepts across the breadth of the UMLS Metathesaurus. 
Terminology 
identification 
code 
Terminology name Number of 
directly linked 
UMLS concepts 
MTH Metathesaurus Names 6174 
CHV CHV 4843 
NCI NCI Thesaurus 4487 
SNOMEDCT_
US 
SNOMED Clinical Terms US Edition 4086 
MSH MeSH 2676 
SNMI SNOMED Intl 1998 2028 
LNC LOINC 2018 
AOD Alcohol and Other Drug Thesaurus 1884 
CSP CRISP Thesaurus 1453 
LCH_NW Library of Congress Subject Headings,     Northwestern University subset 1146 
SNM SNOMED 1982 947 
LCH Library of Congress Subject Headings (Division, Policy, Policy, & Office, 2012) 929 
NCI_NCI-
GLOSS 
NCI Dictionary of Cancer Terms 832 
NCI_CDISC Clinical Data Interchange Standards Consortium 816 
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HL7V3.0 HL7 Version 3.0 708 
NDFRT National Drug File - Reference Terminology 642 
NCI_FDA U.S. Food and Drug Administration 564 
OMIM OMIM 486 
MEDLINEPL
US 
MedlinePlus 433 
DXP DXplain 368 
NCI_NICHD National Institute of Child Health and Human Development 363 
HL7V2.5 HL7 Version 2.5 348 
ICD10CM ICD-10-CM 338 
COSTAR COSTAR 322 
CST COSTART 298 
ICD9CM ICD-9-CM 271 
HPO HPO 264 
MTHICD9 ICD-9-CM Entry Terms 227 
ATC Anatomical Therapeutic Chemical (ATC) classification system 206 
PDQ PDQ 203 
RXNORM RXNORM 193 
FMA Foundational Model of Anatomy 178 
VANDF National Drug File 178 
UWDA Digital Anatomist 157 
NCI_CTCAE Common Terminology Criteria for Adverse Events 145 
MTHSPL FDA Structured Product Labels 136 
CCS Clinical Classifications Software 116 
ICF-CY 
International Classification of Functioning, 
Disability and Health for Children and Youth 
(Simeonsson et al., 2003) 
107 
HGNC HUGO Gene Nomenclature Committee 107 
ICF International Classification of Functioning, Disability and Health 101 
USPMG USP Model Guidelines 95 
NCI_UCUM Unified Code for Units of Measure (Schadow & McDonald, 2005) 79 
NCI_BRIDG Biomedical Research Integrated Domain Group Model 74 
GO Gene Ontology 66 
ICPC ICPC 64 
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QMR Quick Medical Reference 62 
NCBI NCBI Taxonomy 44 
NCI_NCPDP National Council for Prescription Drug Programs 43 
NCI_CareLex Content Archive Resource Exchange Lexicon 35 
NCI_DCP NCI Division of Cancer Prevention Program 33 
AIR AI/RHEUM 30 
NCI_CDC U.S. Centers for Disease Control and Prevention 30 
MCM Glossary of Clinical Epidemiologic Terms 28 
NCI_DTP (NCI) Developmental Therapeutics Program 26 
NCI_CRCH Cancer Research Center of Hawaii Nutrition Terminology 25 
NCI_CTEP-
SDC 
Cancer Therapy Evaluation Program - Simple 
Disease Classification 24 
NCI_NCI-HL7 NCI Health Level 7 23 
MTHMST Minimal Standard Terminology (UMLS) 22 
AOT Authorized Osteopathic Thesaurus 19 
NCI_ICH International Conference on Harmonization 17 
MTHHH HCPCS Hierarchical Terms (UMLS) 13 
HCPCS HCPCS 12 
NCI_KEGG KEGG Pathway Database 12 
SPN Standard Product Nomenclature 12 
NCI_DICOM Digital Imaging Communications in Medicine 11 
ICD10PCS ICD-10-PCS 11 
SOP Source of Payment Typology 6 
RAM Clinical Concepts by R A Miller 5 
SRC Source Terminology Names (UMLS) 1 
CVX Vaccines Administered 1 
 
9.3 List of KFF categories, together with indicators used for measurement. 
KFF category 
types Conceptual indicators  
Indicators 
Neighborhood 
and Physical 
Environment 
  
  
  
Housing 
 
 
 
 
  
Households with telephone 
Households with plumbing 
Total housing units 
Median year structure was built 
Monthly housing cost 
Homeless population 
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Income spent on housing 
Transportation Population with private transportation 
Population dependent on public 
transportation 
Safety Juvenile offense charges 
All crimes 
Feelings of safety 
Firearm ownership 
Lighted walkways 
Parks Access to parks 
Economic 
Stability 
Employment 
 
 
 
 
Employed labor force 
Unemployed labor force 
Population employed in construction 
Population employed in 
manufacturing 
Families with two working parents 
Income Median family income 
Median household income 
Population with poverty status 
determined 
Population living below 125% poverty 
Population living below 185% poverty 
Supportive assistance Households with cash public 
assistance 
Education Higher education Population with college or graduate 
school,  
population with a bachelor’s degree or 
higher 
population with a high school diploma 
only 
Language Adults in workforce speaking English 
Adults in workforce speaking only 
languages other than English 
Seniors speaking English 
Seniors speaking only languages other 
than English 
Households speaking English 
Households speaking only languages 
other than English 
Food 
  
Hunger Household food affordability  
Access to healthy options Access to full-service grocery store  
Fast food consumption  
Social integration Access to community center/library  
Support systems Neighbors are willing to help  
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9.4  Categories of clinical data used in decision-model building 
Patient demographics:  
Gender, race, age, race/ethnicity 
 
Chronic conditions:  
Arthritis, asthma, coronary artery disease, cardiac arrhythmias, hypertension, 
hyperlipidemia, stroke, autism spectrum disorder, cancer, chronic kidney disease, chronic 
obstructive pulmonary disease, dementia, depression, diabetes, hepatitis, HIV AIDS, 
osteoporosis, schizophrenia 
 
Acute conditions:  
A total of 1,116 different acute diagnoses 
 
Previous visit history:  
Emergency visits, impatient visits, outpatient visits  
Community 
and social 
context 
  
  
Community engagement Registered to vote 
Discrimination Acceptance by healthcare provider 
Feelings of discrimination 
Healthcare 
system 
  
  
  
Health coverage Population without health insurance 
No visit to doctor due to high cost 
No Rx med due to high cost 
Provider availability  Have single primary care provider?  
Quality of care Individual’s general health  
# Days poor physical health  
# Days poor mental health 
EVER diagnosed with heart event  
EVER diagnosed with depression  
EVER diagnosed with high cholesterol  
EVER diagnosed with asthma  
EVER diagnosed with diabetes  
EVER diagnosed with HBP  
Life expectancy 
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9.5 Precision-Recall curve for each decision model under study 
 
Patients with a prior diagnosis of depression (Group A) 
 
 
Patients with a Charlson Index of <=1 (Group B) 
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Patients with a Charlson Index of <=2 (Group C) 
 
 
All unique patients in groups A-C (Group D) 
 
 77 
9.6 List of 20 top features (Ranked in order of best to worst) for each decision 
model, together with their LASSO scores 
# Master 
patient 
population  
Group A Group B Group C Group D 
1 Essential 
(primary) 
hypertensio
n 
(1.0) 
Number of 
outpatient 
visits > last 30 
days 
(1.0) 
Number of 
outpatient 
visits > last 
30 days (1.0) 
Number of 
outpatient 
visits > last 30 
days (1.0) 
Number of 
outpatient 
visits > 30 
days (1.0) 
2 Depressive 
disorder 
(0.765) 
Schizophrenia 
(1.0) 
Depressive 
disorder (1.0) 
 
Number of 
inpatient visits 
prior to last 30 
days (1.0) 
Depressive 
disorder (1.0) 
 
3 Dorsalgia 
(0.5) 
Hyperlipidemi
a (1.0) 
Charlson 
Index (1.0) 
Number of 
inpatient visits 
during last 30 
days (1.0) 
Gender (1.0) 
4 Nicotine 
dependence 
(0.5) 
External 
injury (1.0) 
Gender (1.0) Hyperlipidemi
a (1.0) 
Essential 
(primary) 
hypertension 
(1.0) 
5 Joint 
disorder 
(0.48) 
Depressive 
disorder (1.0) 
 
Essential 
(primary) 
hypertension 
(1.0) 
 
External injury 
(1.0) 
Diabetes 
mellitus 
(1.0) 
6 Gender 
(0.48) 
Arthritis (1.0) Episodic 
mood 
disorders 
(1.0) 
Depressive 
disorder (1.0) 
Charlson 
Index (1.0) 
7 Encounter 
for 
contraceptiv
e 
managemen
t (0.475) 
Nonspecific 
findings on 
examination 
of blood 
(1.0) 
Diabetes 
mellitus (1.0) 
Charlson Index 
(1.0) 
Asthma (1.0) 
8 Routine 
general 
medical 
examination 
(0.475) 
Other cerebral 
degenerations 
(1.0) 
Hyperlipide
mia (0.87) 
 
Arthritis (1.0) Disorders of 
lipoid 
metabolism 
(0.95) 
9 Examinatio
n of eyes 
and vision 
Cancer 
(0.995) 
 
Cancer (0.77) Age (1.0) Other cerebral 
degenerations  
(0.9) 
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(0.465) 
10 Abdominal 
and pelvic 
pain 
(0.465) 
Vitamin D 
deficiency 
(0.995) 
Other 
cerebral 
degeneration
s 
(0.715) 
Gender (1.0) Symptoms of 
the respiratory 
system and 
other chest 
symptoms 
(0.85) 
11 Encounter 
for 
screening 
for 
malignant 
neoplasms 
(0.46) 
Charlson 
Index (0.985) 
 
Asthma (0.6) Chronic kidney 
disease (1.0) 
 
Bronchitis 
(0.8) 
12 Soft tissue 
disorders 
(0.46) 
Episodic 
mood 
disorders  
(0.805) 
Number of 
inpatient 
visits prior to 
last 30 days 
(0.555) 
Chronic airway 
obstruction 
(1.0) 
 
Number of 
emergency 
department 
visits prior to 
last 30 days 
(0.77) 
13 Long-term 
(current) 
drug therapy 
(0.455) 
Cataract (0.8) Bronchitis 
(0.555) 
 
Other and ill-
defined 
cerebrovascula
r disease (1.0) 
Number of 
inpatient visits 
prior to last 30 
days (0.723) 
14 Number of 
outpatient 
visits prior 
to last 30 
days (0.43) 
Asthma (0.59) External 
injury (0.55) 
Heart failure 
(1.0) 
Hyperlipidemi
a (0.66) 
15 Episodic 
mood 
disorders 
(0.22) 
Heart failure 
(0.545) 
Arthritis 
(0.545) 
Acute 
myocardial 
infarction 
(0.995) 
 
Disorders of 
fluid 
electrolyte 
and acid-base 
balance 
(0.635) 
16 Pain in 
throat and 
chest 
(0.175) 
Number of 
emergency 
department 
visits during 
last 30 days 
(0.54) 
Disorders of 
fluid 
electrolyte 
and acid-base 
balance 
(0.515) 
Essential 
(primary) 
hypertension 
(0.95) 
 
Persistent 
mental 
disorders 
(0.6) 
17 Encounter 
for 
screening 
for 
infectious 
Chronic 
kidney 
disease  
(0.525) 
Nondepende
nt abuse of 
drugs 
(0.51) 
Asthma (0.925) Chronic 
obstructive 
pulmonary 
disease 
(0.612) 
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and parasitic 
diseases 
(0.175) 
18 Encounter 
for other 
special 
examination 
without 
complaint 
(0.15) 
Sprain of neck 
(0.52) 
Number of 
inpatient 
visits during 
last 30 days 
(0.49) 
Nondependent 
abuse of drugs 
(0.9) 
Arthritis (0.6) 
19 Anxiety, 
dissociative 
and 
somatoform 
disorders  
(0.125) 
Gender 
(0.515) 
Number of 
emergency 
department 
visits prior to 
last 30 days 
(0.49) 
Diabetes 
mellitus 
(0.85) 
Acute 
myocardial 
infarction 
(0.55) 
20 Diabetes 
mellitus 
(0.05) 
Attention 
deficit 
disorder 
without 
mention of 
hyperactivity 
(0.515) 
Persistent 
mental 
disorders  
(0.48) 
Other 
peripheral 
vascular 
disease 
(0.85) 
Dementia 
(0.51) 
 
9.7 Co-occurrence of top 20 features across each of the patient populations under 
test (1 = most important, 20 == least important) 
 
Feature 
Master 
patient 
population 
Group A Group B Group C Group D 
Essential (primary) 
hypertension 1   5 16 4 
Depressive disorder  2 5 2 6 2 
Dorsalgia 3         
Nicotine dependence 4         
Joint disorder 5         
Gender 6 19 4 10 3 
Encounter for 
contraceptive 
management 
7         
Routine general medical 
examination 8         
Examination of eyes and 
vision 9         
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Abdominal and pelvic 
pain 10         
Encounter for screening 
for malignant neoplasms 11         
Soft tissue disorders 12         
Long-term (current) 
drug therapy 13         
Number of outpatient 
visits prior to last 30 
days  
14 1   1 
1 
53.18  1 
Episodic mood disorders  15 12 6     
Pain in throat and chest 16         
Encounter for screening 
for infectious and 
parasitic diseases 
17         
Encounter for other 
special examination 
without complaint 
18         
Anxiety, dissociative, 
and somatoform 
disorders  
19         
Diabetes mellitus 20   7 19 5 
Schizophrenia   2       
Hyperlipidemia   3 8 4 14 
External injury   4 14 5   
Arthritis   6 15 8 18 
Nonspecific findings on 
examination of blood   7       
Other cerebral 
degenerations   8 10   9 
Cancer   9 9     
Vitamin D deficiency   10       
Charlson Index   11 3 7 6 
Cataract   13       
Asthma   14 11 17 7 
Heart failure   15   14   
Number of emergency 
department visits during 
last 30 days    
16 
      
Chronic kidney disease    17   11   
Sprain of neck   18       
Attention deficit 
disorder without 
mention of hyperactivity   
20 
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Number of inpatient 
visits prior to last 30 
days    12 2 13 
Bronchitis     13   11 
Disorders of fluid 
electrolyte and acid-base 
balance      16   15 
Nondependent abuse of 
drugs     17 18   
Number of inpatient 
visits during last 30 days      18 3   
Number of emergency 
department visits prior 
last 30 days      19   12 
Persistent mental 
disorders      20   16 
Age       9   
Chronic airway 
obstruction       12   
Other and ill-defined 
cerebrovascular disease       13   
Acute myocardial 
infarction       15 19 
Other peripheral 
vascular disease       20   
Disorders of lipoid 
metabolism         8 
Symptoms involving 
respiratory system and 
other chest symptoms         10 
Chronic obstructive 
pulmonary disease          17 
Dementia         20 
 
9.8 List of patient-centric SDH and number of patients reporting, as extracted from 
the master patient population 
Id Description ICD-9 and ICD-10 codes # of 
patients 
reporting 
1 Problems related to education 
and literacy 
Z55.* 
V62.3 
127 
2 Problems related to 
employment and 
unemployment 
Z56.* 
V62.0, V62.1, V62.2 
113 
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3 Occupational exposure to risk 
factors 
Z57.* 
V15.85 
29 
4 Exposure to noise, air, water, 
soil, pollution, radiation, etc. 
Z58.* 0 
5 Problems related to housing and 
economic circumstances 
Z59.* 
V60.0, V60.1, V60.2, V60.6, 
V60.89,V60.9 
631 
6 Problems related to social 
environment  
Z60.* 
V62.4, V60.3 
30 
7 Problems related to negative 
life events in childhood 
Z61.* 0 
8 Problems related to upbringing Z62.* 
V60.81, V61.29 
V61.8,  
51 
9 Other problems related to 
primary support group, 
including family circumstances 
Z63.* 
V61.3, V61.41 
V61.42, V61.49 
V61.8, V61.9 
V62.82, V61.01, V61.02, 
V61.03, V61.04, V61.05, 
V61.06, V61.07, V61.08, V61.09 
446 
10 Problems related to certain 
psychosocial circumstances 
Z64.* 
V61.5, V61.6, V61.7 
42 
11 Problems related to other 
psychosocial circumstances 
Z65.* 
V62.21, V62.22, V62.29, 
V62.5, V62.81, V62.89, V62.9 
V11.0, V11.1, V11.2, V11.3, 
V11.9 
410 
12 Problems related to medical 
facilities and other health care 
Z75.* 
V60.5, 
V63.0,V63.1,V63.2,V63.8,V63.9 
4 
 
9.9 List of Aggregate-level SDH extracted from the Polis Center 
Column name Description 
COLLEGEN1 
Percent of Population Age 3 and Over in College or Graduate 
School 
BACHMOREN1 
Percent of Population Age 25 and Over with a Bachelor’s 
Degree or Higher 
POPWDIPN1 
Percent Population (Age 25 and Over) With High School 
Diploma Only (Includes Equivalency) 
CMB30PMN2 
Percent of Occupied Housing units (combination of rental and 
owner) Whose Occupants Pay 30% or More of Income for 
Housing Costs 
TOTOWNOCN1 Percent of All Occupied Units that are Owner Occupied 
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HHLDFSN1 
Percent of Households with Cash Public Assistance or Food 
Stamps/SNAP 
MEDFMLYINC Median Family Income 
MEDHHLDINC Median Household Income 
TOTPOPNON1 Percent of Population All Ages Without Health Insurance 
TOTUNEMPN2 
Percent of Labor Force Age 16 and Over Who Are 
Unemployed 
LANGENGLN1 
Percent of All Households with Household Language of 
English 
PERINPOVN1 
Percent of Population in Poverty For Whom Poverty Status is 
Determined 
POVB125N1 Percent of Population Living below 125% Poverty 
POVB185N1 Percent of Population Living below 185% Poverty 
NONCARN1 
Percent of Workers Age 16 and Over Who did not Drive a Car, 
Truck or Van as their Means of Transportation to Work 
 Life Expectancy Life Expectancy 
nbh_Safe 
I feel safe in my neighborhood (Mean 1 Strong agree - 5 Strong 
Disagree) 
nbh_Help 
Neighbors are willing to help (Mean 1 Strong agree - 5 Strong 
Disagree) 
nbh_Blight 
Neighborhood has blight (Mean 1 Strong agree - 5 Strong 
Disagree) 
nbh_Pave Neighborhood has paved walkways (% reporting yes) 
nbh_Wheelch 
Neighborhood has walkways with wheeled access (% 
reporting yes) 
nbh_Light Neighborhood has lighted walkways (% reporting yes) 
nbh_Conn 
Neighborhood walkways connect to other major 
streets/neighborhoods (% reporting yes) 
nbh_Groc 
Full service grocery store within 10-min walk from home (% 
reporting yes) 
nbh_Commctr 
Community center/library within 10-min walk from home (% 
reporting yes) 
nbh_Park 
Park/greenway/playground within 10-min walk from home (% 
reporting yes) 
nbh_PubTrans 
Bus/public transportation within 10-min walk from home (% 
reporting yes) 
smokcurr Current smoker (% reporting yes) 
pacalc 
Engages in moderate physical activity for 150 min or more per 
week (% reporting yes) 
cd_drinkbinge 
# occasions in past 30 days: 4/more drinks (F) or 5/more drinks 
(M) (Mean of 0 to 30 days) 
cd_violc 
Member of household was a victim of violence in past 12 
months (% reporting yes) 
cd_gun Firearm in home (% reporting yes) 
cd_addict Member of household ever addicted to meds (% reporting yes) 
 84 
hth_gen 
Describe own general health (Mean of 1 Excellent 2 Good 3 
Fair 4 Poor 5 Very poor) 
hth_daysphys # Days poor physical health (Mean of 0 to 30 days) 
hth_daysment # Days poor mental health (Mean of 0 to 30 days) 
cd_heart EVER diagnosed with Heart Event (% reporting yes) 
cd_depr EVER diagnosed with Depression (% reporting yes) 
cd_chol EVER diagnosed with Hi Chol (% reporting yes) 
cd_asth EVER diagnosed with Asthma (% reporting yes) 
cd_diab EVER diagnosed with Diab (% reporting yes) 
cd_hbp EVER diagnosed with HBP (% reporting yes) 
fd_fastfood Number of times ate fast food last 7 days (Mean) 
fd_foodsecure 
Describe household food affordability last 12 months (Mean of 
1 “Could always afford enough food to eat,” 2 “Sometimes 
couldn’t afford enough food to eat,” 3 “Often couldn’t afford 
enough food to eat” 
hth_hrstv Hours TV per day (Mean) 
hc_1provdr Have single primary care provider? (% reporting yes) 
hc_costdr No visit to Dr. in last 12 months due to hi $ (% reporting yes) 
hc_costmed No Rx med in last 12 months due to hi $ (% reporting yes) 
hc_respect 
Feel accepted/respected by current healthcare provider (% 
reporting yes) 
 
9.10 Distribution of patient populations across demographic areas 
 Group A Group B Group C Group D 
Patient set 
size 
11,349 29,840 7,415 84,317 
Distribution 
across HPA 
19/19 19/19 19/19 19/19 
Distribution 
across Zip 
codes 
37/38 37/38 37/38 38/38 
Distribution 
across census 
tracts 
224/224 224/224 221/224 224/224 
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